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Autophagy, a lysosomal degradation pathway, plays an essential role in multiple aspects of 35 
immunity, including immune system development, regulation of innate and adaptive 36 
immune and inflammatory responses, selective degradation of intracellular microbes, and 37 
host protection against infectious diseases1,2. Unlike autophagy induction by stimuli such as 38 
nutrient deprivation and mTOR suppression, little is known about how autophagosomal 39 
biogenesis is initiated in mammalian cells in response to viral infection. We performed 40 
genome-wide siRNA screens and found that the endosomal protein sorting nexin 5 41 
(SNX5)3,4 is essential for virus-induced, but not for basal, stress- or endosome-induced, 42 
autophagy. We showed that SNX5 deletion increases cellular susceptibility to viral infection 43 
in vitro, and that Snx5 knockout in mice enhances lethality after infection with multiple 44 
human viruses. Mechanistically, SNX5 interacts with beclin 1 and ATG14-containing Class 45 
III phosphatidylinositol 3-kinase (PI3KC3) complex 1 (PI3KC3-C1), increases the lipid 46 
kinase activity of purified PI3KC3-C1, and is required for endosomal generation of PI3P 47 
and recruitment of the PI3P-binding protein WIPI2 to virion-containing endosomes. These 48 
findings identify a context- and organelle-specific mechanism – SNX5-dependent PI3KC3-49 
C1 activation at endosomes – for autophagy initiation during viral infection.  50 
To identify cellular factors required for virus-induced autophagy, we performed high-content 51 
image-based genome-wide siRNA screens in HeLa cells infected with Sindbis virus (SIN) (an 52 
enveloped single-stranded RNA virus) and a genetically engineered strain of herpes simplex 53 
virus type 1 (HSV-1) (an enveloped double-stranded DNA virus). The latter contains a deletion 54 
in the beclin 1-binding domain (BBD) of the HSV-1 neurovirulence protein ICP34.5 that 55 
prevents it from inhibiting host autophagy (HSV-1ΔBBD)5. The autophagy pathway targets these 56 
viruses in vitro, protecting mice against lethal central nervous system (CNS) infection5-7. Both 57 
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viruses induce autophagy in HeLa and HeLa/GFP-LC3 cells as demonstrated by increased GFP-58 
LC3 (a marker of autophagosomes) puncta, increased conversion of LC3-I to the lipidated 59 
autophagosome-associated form LC3-II; and degradation of the autophagy substrate 60 
p62/SQSTM1 (Extended Data Fig. 1a-i). These changes reflect autophagic flux, as GFP-LC3 61 
puncta and LC3-II accumulation increased further upon lysosomal inhibition with bafilomycin 62 
A1, which also decreased p62/SQSTM1 degradation. This autophagic flux was reduced by 63 
siRNA knockdown of essential autophagy genes ATG7 and ATG13, as well as pharmacological 64 
inhibition with the Class III phosphatidylinositol-3 kinase (PI3KC3, also known as PIK3C3 or 65 
VPS34) inhibitor, PIK-III (Extended Data Fig. 1). These results indicate a role for the autophagy 66 
protein conjugation systems, the autophagy-initiating ULK1 complex and the PI3KC3 complex, 67 
involved in autophagosome membrane nucleation, in virus-induced autophagy.  68 
 Primary screens of a pooled siRNA oligonucleotide library targeting 18,115 unique human 69 
genes showed that knockdown of 310 genes resulted in fewer GFP-LC3 puncta in SIN- and/or 70 
HSV-1ΔBBD-infected HeLa/GFP-LC3 cells but not in mock-infected cells (Extended Data Fig. 71 
2a-e). We performed deconvolution screens with four individual siRNA oligonucleotides per 72 
candidate gene. Gene knockdown with two or more siRNA oligonucleotides decreased numbers 73 
of virus-induced GFP-LC3 puncta for 216 of 310 (69.7%) genes (confirmed hits) (Fig. 1a, 74 
Extended Data Fig. 2f, g). 75 
 Bioinformatic analyses showed enrichment for gene sets associated with biological processes 76 
and molecular functions, including protein complex assembly, transport, kinases and certain 77 
transcription factors (Extended Data Fig. 2h, i), as well as NLRX1 which promotes virus-induced 78 
autophagy8. We focused on endosomal proteins, as most viruses enter cells through a route that 79 
converges at the endolysosomal system9. Cytoplasmic entry of SIN and HSV-1ΔBBD via fusion 80 
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at the plasma membrane resulted in fewer GFP-LC3 puncta than normal entry (Extended Data 81 
Fig. 3a-d), underscoring the importance of endosomal entry for virus-induced autophagy. We 82 
focused further analyses on the endosomal protein sorting nexin 5 (SNX5). SNX5 encodes a 83 
predicted Phox (PX) domain, a conserved protein domain that binds phosphoinositides, such as 84 
phosphatidylinositol 3-phosphate (PI3P). Additionally, SNX5 contains a Bin/Amphiphysin/Rvs 85 
(BAR) domain, which is essential for sensing and driving membrane curvature10,11. Critical early 86 
events during autophagosomal biogenesis include PI3P generation by the PI3KC3 complex I 87 
(PI3KC3-C1, also known as PIK3C3-C1) and membrane remodeling12. Thus, we hypothesized 88 
that SNX5 might act during viral endosomal entry to increase endosome-based PI3P generation 89 
and initiate autophagosome formation. 90 
 Knockdown of SNX5, and the related gene SNX32, decreased SIN- and HSV-1ΔBBD-91 
induced autophagy by a magnitude similar to ATG7 knockdown (Fig. 1b, Extended Data Fig. 3e-92 
i). Importantly, siRNA knockdown of SNX5 or SNX32 decreased autophagy induction by six 93 
additional pathogenic human viruses, including Zika virus13, West Nile virus (WNV)14, 94 
chikungunya virus (CHIKV)15, poliovirus16, Coxsackievirus B3 (CVB3)17 and influenza A virus 95 
(IAV)18 (Fig. 1b, Extended Data Fig. 3e-i). To rule out off-target siRNA effects, we generated 96 
HeLa SNX5KO cells using the CRISPR/Cas9 system and stably transfected them with GFP-LC3 97 
(Extended Data Fig. 3j). SNX5KO/GFP-LC3 cells were deficient in SIN- and HSV-1ΔBBD-98 
induced autophagy, but this defect was fully rescued by reconstitution of wild-type SNX5 in two 99 
independent SNX5KO/GFP-LC3/SNX5 cell clones (Extended Data Fig. 3k). These results indicate 100 
that SNX5 is required for autophagy induced by a broad range of viral pathogens. 101 
 Neither siRNA knockdown of SNX5 or SNX32, nor CRISPR knockout of SNX5, altered basal 102 
autophagy, starvation-induced autophagy, or mTOR inhibition-induced autophagy (Extended 103 
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Data Fig. 4a-c). SNX5KO and wild-type HeLa/GFP-LC3 cells showed identical formation of LC3-104 
positive Group A Streptococcus containing vacuoles19 (Extended Data Fig. 4d, e), indicating that 105 
xenophagy of a bacterium that enters cells by endosomes does not require SNX5. SNX5 was also 106 
dispensable for osmotic stress-induced LC3-recruitment to endolysosomal structures labeled by 107 
EEA1 and LAMP120 (Extended Data Fig. 4f, g). Furthermore, SNX5KO and wild-type HeLa cells 108 
exhibited similar monensin-induced LC3 recruitment to latex bead-containing phagosomes, an 109 
assay for measuring LC3-associated phagocytosis (LAP) in non-phagocytic cells21 (Extended 110 
Data Fig. 4h, i). Thus, SNX5 is specific for virus-induced autophagy, and is not required for 111 
general autophagy or non-canonical forms of autophagy that require endolysosomal or 112 
phagosomal LC3 recruitment.  113 
 siRNA knockdown of the essential retromer gene VPS29 did not alter virus-induced 114 
autophagy (Fig. 1b, Extended Data Fig. 3e, h), but impaired retromer-dependent retrograde 115 
transport of glucose transporter 1 (GLUT1) as demonstrated by increased lysosomal localization 116 
of mis-sorted GLUT1 (Extended Data Fig. 5a-f). Consistent with the reported functional 117 
redundancy of SNX5, SNX6 and SNX32 in retromer activity4,22, neither knockdown of SNX5 nor 118 
SNX32 impaired GLUT1 trafficking. Early endocytic function was identical in SNX5KO and wild-119 
type HeLa cells, as measured by recycling kinetics of the transferrin receptor (Extended Data 120 
Fig. 5g-i). Late endocytic function also remained unchanged in SNX5KO cells, as measured by 121 
rates of epidermal growth factor receptor (EGFR) degradation (Extended Data Fig. 5j, k). Thus, 122 
the requirement for SNX5 in virus-induced autophagy is unlikely related to a role in retromer 123 
function or other endocytic functions. 124 
 Since autophagy restricts the replication of certain viruses in vitro and protects against 125 
certain viral diseases in vivo1,2, we studied viral infection in SNX5-deficient cells and 126 
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pathogenesis in Snx5-/- mice23. We focused on SIN, HSV-1ΔBBD, WNV, and CHIKV viruses for 127 
which existing data indicate the importance of autophagy in controlling viral disease5-7,15,24,25. 128 
For the first three, which are neuronotropic and cause fatal encephalitis in mice, we used an 129 
intracranial model of in vivo infection to study virus-host interactions in neurons without 130 
confounding effects of other stages of pathogenesis, including viral dissemination from the 131 
periphery and systemic immune responses that do not penetrate the blood-brain barrier. For 132 
CHIKV, we used an established model of peripheral viral infection in neonatal mice, as previous 133 
studies have reported a protective role of autophagy15,25. SNX5 deletion in HeLa cells increased 134 
susceptibility to SIN, HSV-1ΔBBD, WNV and CHIKV infection in viral infectivity assay 135 
(Extended Data Fig. 6a-d). Viral multi-step growth also increased in SNX5KO cells (Extended 136 
Data Fig. 6e-h), as well as in primary mouse embryonic fibroblasts (MEFs) derived from Snx5-/- 137 
compared to wild-type littermates (Extended Data Fig. 6i-l). Viral infectivity and replication was 138 
not increased in SNX5KO cells or Snx5-/- MEFs after infection with autophagy-suppressing 139 
viruses, including SIN.dnAtg5 (expressing a dominant negative Atg5) and HSV-1ΔBBD-MR (a 140 
marker-rescued strain of HSV-1ΔBBD expressing wild-type ICP34.5, which inhibits host 141 
autophagy by binding beclin 1) (Extended Data Fig. 6m-r). Increased viral replication in SNX5 142 
deficiency was not due to alterations in viral entry (Extended Data Fig. 6s, t) or virus-induced 143 
interferon signaling (Extended Data Fig. 6u, v), and SNX5 mRNA did not decrease upon 144 
infection (Extended Data Fig. 6w). Therefore, SNX5 restricts viral replication in a cell 145 
autonomous fashion by an autophagy-dependent mechanism.  146 
 Neonatal Snx5-/- mice were more susceptible to lethal infection with SIN, CHIKV, or WNV 147 
than Snx5+/+ counterparts, and adult Snx5-/- mice were more susceptible to lethal HSV-1ΔBBD 148 
encephalitis than their wild-type littermates (Fig. 1c). The brains of neonatal SIN-infected and 149 
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adult HSV-1ΔBBD-infected Snx5-/- mice revealed increased viral titers and neuronal death at 150 
certain time points after infection (Extended Data Fig. 7a-f). This Snx5-mediated protective 151 
effect is likely related to autophagy induction, as mortality did not differ between Snx5+/+ and 152 
Snx5-/- mice infected with SIN.dnAtg5 or HSV-1ΔBBD-MR that inhibit neuronal autophagy5,6 153 
(Fig. 1c, Extended Data Fig. 7g). Thus, Snx5 is a previously undescribed host factor that 154 
functions in antiviral defense in vivo.  155 
We evaluated whether SNX5 interacts with autophagy-specific PI3KC3-C1 complexes, 156 
which function in autophagosome initiation or PI3KC3-C2 complexes, which function in 157 
autophagosome maturation and endocytic trafficking12. As demonstrated by the presence of 158 
ATG14, but not UVRAG (Fig. 2a), only PI3KC3-C1 complexes co-immunoprecipitated with 159 
SNX5. This difference is not due to alterations in assembled PI3KC3-C1 or PI3KC3-C2 160 
complexes, as both ATG14 and UVRAG co-immunoprecipitated with beclin 1 (Fig. 2b). The 161 
SNX5-PI3KC3-C1 interaction does not require PI3KC3-C1 lipid kinase activity, as it is not 162 
diminished by treatment with the PI3KC3-specific inhibitor PIK-III (Fig. 2a, b), which blocks 163 
autophagy during baseline conditions, starvation, mTOR inhibition, and viral infection 164 
(Extended Data Figs. 1l, 8a-e). Recombinant SNX5 interacts with intact PI3KC3-C1, but not 165 
PI3KC3-C2, complexes (Fig. 2c-e, Extended Data Fig. 8f), indicating a direct SNX5-PI3KC3-C1 166 
interaction. The interaction specificity may represent binding of SNX5 to the PI3KC3-C1-167 
specific protein ATG14, an autophagy protein that senses membrane curvature26, or other 168 
conformational differences between PI3KC3-C1 and PI3KC3-C227,28.  169 
Our findings suggest that SNX5 acts upstream of PI3P generation to regulate PI3KC3-C1 170 
activation during viral infection. We therefore studied the effects of recombinant SNX5 on the 171 
lipid kinase activity of Large Unilamellar Vesicles prepared by Extrusion Technique 172 
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(LUVETs)29,30 with two distinct membrane curvatures employing a lipid mixture that resembles 173 
endosomal lipid composition31,32. On smaller LUVETs, PI3KC3-C1 complexes exhibited 174 
approximately three-fold higher lipid kinase activity which was abolished by PIK-III (Fig. 2f). 175 
Compared to SUMO control protein (Fig. 2c), recombinant SUMO-SNX5 increased PI3KC3-C1 176 
activity on larger LUVETs in a dose-dependent manner (Fig. 2g, left); the magnitude of this 177 
effect was decreased on smaller LUVETs with greater membrane curvature (Fig. 2g, right). 178 
Positively charged residues in the concave surface of BAR domains mediate membrane 179 
association of BAR-containing proteins via electrostatic interaction with the lipid bilayer11. 180 
K429E, K430E and R431E mutations in the BAR domain of SNX1, a sorting nexin closely 181 
related to SNX5, block its association with membranes and the ability to induce membrane 182 
remodeling33. To investigate whether the corresponding positively charged BAR domain 183 
residues in SNX5 are required for its effect on PI3KC3-C1 activity, we aligned amino acid 184 
sequences of SNX5 and SNX1 and identified residues K328, R330 and K332, which were 185 
substituted with glutamic acid (SNX5 EEE) (Extended Data Fig. 8g, h). Unlike wild-type 186 
SUMO-SNX5, the EEE mutant protein failed to enhance PI3KC3-C1 activity on larger LUVETs 187 
(Fig. 2g). SUMO-SNX5 EEE did not bind PI3KC3-C1 complexes (Fig. 2e), indicating that the 188 
tip region of the BAR domain carrying these evolutionarily conserved residues is required for 189 
interaction with PI3KC3-C1. A previous study revealed that PI3KC3-C1 has diminished capacity 190 
to generate PI3P on low-curvature membranes such as giant unilamellar vesicles28. Our data 191 
suggest that SNX5, by enhancing local membrane curvature through its BAR domain, facilitates 192 
PI3KC3-C1-mediated PI3P generation on flatter membranes that resemble the endosome.  193 
We next performed cryogenic electron microscopy (cryo-EM) of the larger LUVETs 194 
incubated with SUMO-SNX5, SUMO-SNX5 EEE or SUMO control protein. In the presence of 195 
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SNX5, but not SUMO-SNX5 EEE, liposomes had increased membrane curvature (Fig. 2h, i). 196 
Thus, at least in vitro, the SNX5 BAR domain is required for increasing liposomal membrane 197 
curvature, a mechanism essential for increased PI3KC3-C1 activity.  198 
Virally-infected SNX5KO cells were defective in endosomal PI3P production, as measured 199 
both by staining with a fluorescent PI3P-binding probe, PX-Alexa55528, and immunostaining for 200 
WIPI2, a PI3P-binding protein and early autophagosome marker34. Defects occurred during SIN 201 
and HSV-1ΔBBD infection, but not at baseline, or upon induction of autophagy by starvation or 202 
mTOR inhibition. The PI3P production defect was rescued by wild-type SNX5 but not mutant 203 
SNX5 EEE (Extended Data Fig. 9). SIN and HSV-1ΔBBD infection increased WIPI2 puncta that 204 
colocalized with EEA1 in parental wild-type and SNX5KO cells reconstituted with wild-type 205 
SNX5, but not in SNX5KO cells or SNX5KO cells reconstituted with SNX5 EEE (Fig. 3a, b). The 206 
defect in endosomal WIPI2 puncta formation in SNX5KO cells was not related to decreased 207 
endosomal localization of beclin 1, ATG14 or VPS34 (Extended Data Fig. 10a). Similar to GFP-208 
LC3 puncta (Extended Data Fig. 1l), the SIN- and HSV-1ΔBBD-induced increase of the PI3P 209 
probe signal and WIPI2 puncta formation in HeLa cells was abolished by PIK-III (Extended 210 
Data Fig. 10b-e). Thus, SNX5 – and residues in its BAR domain predicted to sense and drive 211 
membrane curvature – are not required for the endosomal localization of PI3KC3-C1, but are 212 
required for the endosomal function of PI3KC3-C1 and PI3P generation in virally-infected cells.  213 
To determine the location of SNX5-dependent PI3KC3-C1 activation, we employed a 214 
Sindbis virus strain expressing mCherry fused to the E2 envelope glycoprotein (SIN.mCherry-215 
E2)35. One hour after infection, SIN.mCherry-E2 was present in EEA1-positive endosomes, 216 
representing endocytosed virions (Fig. 3c). An increased percentage of mCherry-E2-positive 217 
EEA1-positive structures with colocalized SNX5 puncta relative to mCherry-E2-negative EEA1-218 
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positive structures (Fig. 3c-e) indicates selective recruitment of SNX5 to virion-containing 219 
endosomes. Similarly, more colocalized WIPI2 puncta (Fig. 3f, g) indicates the selective 220 
generation of PI3P at virion-containing endosomes. WIPI2 puncta formation at virion-containing 221 
endosomes decreased in SIN.mCherry-E2-infected SNX5KO cells; this defect was rescued by 222 
wild-type SNX5 but not SNX5 EEE (Fig. 3f, g). Thus, SNX5 functions specifically at virion-223 
containing endosomes to increase PI3KC3-C1 activity and autophagosomal biogenesis. 224 
Our findings suggest that stimuli inside an organelle may be linked to organelle-specific 225 
initiation of autophagosomal biogenesis. When viruses enter endosomes, SNX5, a protein that 226 
senses and drives membrane curvature, specifically localizes to virion-containing early 227 
endosomes and functions to initiate activation of the ATG14-containing PI3KC3-C1 complex, 228 
the first stage of autophagosome formation. This mechanism is unique to viral infections and not 229 
to other forms of stress-induced autophagy (e.g. nutrient deprivation and mTOR inhibition) or 230 
non-canonical forms of autophagy (e.g. bacterial xenophagy, osmotic stress-induced autophagy 231 
and LAP), suggesting distinct cellular mechanisms for activating PI3KC3-C1 and autophagy in 232 
response to different stress stimuli. We speculate that as-of-yet unidentified proteins that regulate 233 
membrane curvature (or other factors that locally govern PI3KC3-C1 activity) serve as crucial 234 
mediators of stimulus-specific autophagy.  235 
The question of how luminal viruses stimulate the SNX5-PI3KC3 axis on the cytoplasmic 236 
face of endosomes remains outstanding. Based on insights from other experimental systems22, 237 
SNX5 may associate with an array of integral membrane proteins to establish a “signature” for 238 
virion-containing endosomes. Evidence that the human cytomegalovirus tegument protein UL35 239 
antagonizes SNX5-mediated antiviral activity36 and that SIN replication is attenuated in SNX5KO 240 
HEK293T cells37 suggests evolutionarily conserved complex mechanisms by which SNX5 241 
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mediates host-virus interactions. Additional structural and microscopy-based studies, requiring 242 
development of specific immuno-electron microscopy-based tools, will be needed to capture the 243 
transient interaction of SNX5 with virion-containing endosomal membranes and to dissect the 244 
precise molecular mechanisms underlying this process.   245 
 246 
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Figure Legends 373 
Fig. 1. SNX5 is required for virus-induced autophagy in vitro and antiviral host defense in 374 
vivo. a, Confirmed hits from deconvolution siRNA screens grouped according to their 375 
requirement for SIN-induced autophagy, HSV-1ΔBBD-induced autophagy, or both. b, GFP-LC3 376 
puncta in HeLa/GFP-LC3 cells treated with indicated siRNAs (72 h) and mock-infected or 377 
infected with indicated virus for 4.5 h. MOI = 5 for HSV-1ΔBBD; 10 for SIN, Zika virus, WNV, 378 
CHIKV and IAV; and 20 for poliovirus and CVB3. Bars represent mean ± s.d. of three 379 
independent replicates (100-150 cells per sample). P-values, one-way ANOVA with Dunnett's 380 
test for multiple comparisons. c, Survival of Snx5+/+ and Snx5-/- mice infected with SIN (strain 381 
dsTE12Q, 1,000 pfu i.c., 7-day-old mice), SIN.dnAtg5 (1,000 pfu i.c., 7-day-old mice), HSV-382 
1ΔBBD (50,000 pfu i.c., 8 to 10-week-old mice), HSV-1ΔBBD-MR (50,000 pfu i.c., 8 to 10-383 
week-old mice), WNV (1 pfu i.c., 5.5-day-old mice) or CHIKV (100,000 pfu s.c., 7-day-old 384 
mice). Results represent combined data for at least three independent experiments per virus; 385 
similar results obtained for each infection. P-values, log-rank test (two-sided).   386 
 387 
Fig. 2. SNX5 interacts with PI3KC3-C1 complex and augments its lipid kinase activity. a, b, 388 
Western blots showing co-immunoprecipitation of endogenous PI3KC3 complex proteins with 389 
SNX5 (a) or beclin 1 (b) in HeLa cells treated with DMSO or PIK-III (5 μM, 1 h). IP, 390 
immunoprecipitates; WCL, whole cell lysates. c, d, Coomassie blue staining of His-tagged 391 
SUMO, SUMO-SNX5 or SUMO-SNX5 EEE (c) or PI3KC3 complexes purified from HEK293F 392 
cells co-transfected with plasmids expressing beclin 1, VPS34, VPS15 and either ATG14 393 
(PI3KC3-C1) or UVRAG (PI3KC3-C2) (d). e, Western blot of His-tagged proteins in eluates 394 
from in vitro binding with PI3KC3 complexes. Similar results for a-e were observed in three 395 
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independent experiments. f, Relative PI3KC3-C1 activity in an in vitro lipid kinase assay using 396 
either PI- or PI+ LUVETs +/- PIK-III (0.5 mM). Bars represent mean ± s.d., n=4 biologically 397 
independent samples. P-values, unpaired two-tailed t-tests. PI3KC3-C1 has higher activity on 398 
smaller PI+ LUVETs (P = 2.1e-8; two-way ANOVA). g, Relative PI3KC3-C1 activity 399 
(normalized to 0 nM SUMO) in an in vitro lipid kinase assay using PI+ LUVETs with indicated 400 
SUMO-fusion protein. Symbols represent mean ± s.d., n=4 biologically independent samples. 401 
The dose-dependent SUMO-SNX5-mediated increase in lipid kinase activity is greater on larger 402 
LUVETs (P = 0.000035; linear regression with three-way interaction term). h, i, Representative 403 
cryo-EM micrographs (h) and violin plots of the radius of curvature for vertex points (i) of larger 404 
PI+ LUVETs incubated for 30 min with buffer alone or indicated proteins (>150 liposomes per 405 
sample). Scale bar, 60 nm. P-values, one-way ANOVA with Dunnett's test for multiple 406 
comparisons. See Supplementary Fig. 1 for gel source data.  407 
 408 
Fig. 3. SNX5 is required for virus-induced endosomal generation of PI3P. a, b, 409 
Representative fluorescent micrographs (a) and quantitation (b) of WIPI2+ (green) and EEA1+ 410 
(red) puncta in indicated cells. Scale bars, 20 μm. Arrows denote representative WIPI2+EEA1+ 411 
puncta (white) that would score positive in b. Insets, 4X magnification of boxed areas. Error 412 
bars, mean ± s.d. (three replicates, 100-150 cells each). c-e, Representative fluorescent 413 
micrographs (c) and quantitation (d, e) of SNX5 endosomal localization in SIN.mCherry-E2-414 
infected HeLa cells (MOI = 10, 1 h). Scale bars, 20 μm. Boxed areas are magnified 9X (right) to 415 
show SNX5 (green), E2 (red) and EEA1 (magenta) and SNX5+E2+EEA1+ colocalization 416 
(yellow). Arrows and arrowheads denote representative SNX5-E2-EEA1+ and SNX5+E2+EEA1+ 417 
endosomes, respectively. Bars in d represent mean ± s.d. of Manders’ overlap coefficient of 418 
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SNX5 and E2+EEA1+ or E2-EEA1+ colocalization (n=10, >40 cells per replicate). e, Violin plots 419 
of percentage of overlapping SNX5+ and E2+EEA1+ or E2-EEA1+ puncta (n=137 cells). f, g, 420 
Representative fluorescent micrographs (f) and quantitation (g) of endosomal WIPI2 puncta in 421 
indicated cells. Scale bars, 20 μm. Boxed areas are magnified 4X (right) to show WIPI2 (green), 422 
E2 (red) and EEA1 (magenta) and WIPI2+E2+EEA1+ colocalization (yellow). Yellow puncta 423 
represent WIPI2+E2+EEA1+ puncta that would score positive in g. Bars in g represent mean ± 424 
s.d. (n=3, 100-150 cells per replicate). P-values, one-way ANOVA with Dunnett's test for 425 
multiple comparisons (b, g) or unpaired two-tailed t-test (d, e). Similar results obtained from 426 
three independent experiments.   427 
  428 
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Extended Data Figure Legends 429 
Extended Data Fig. 1. SIN and HSV-1ΔBBD increase autophagy in HeLa cells via an 430 
ATG7-, ATG13-, and PI3KC3-dependent mechanism. a-c, Representative fluorescent 431 
micrographs (a) and quantitation (b, c) of GFP-LC3 puncta (autophagosomes) in HeLa/GFP-432 
LC3 cells treated with non-targeting control siRNA (NC) or ATG7 siRNA for 72 h and then 433 
mock-infected or infected with SIN or HSV-1ΔBBD (at a multiplicity of infection [MOI] of 10 434 
and 5, respectively; 4.5 h) in the presence or absence of the lysosomal inhibitor bafilomycin A1 435 
(Baf A1, 100 nM) for 1 h prior to fixation. Scale bars, 20 μm. Arrows denote representative 436 
autophagosomes that would be scored as positive in b and c. The box plot with whiskers from 437 
minimum to maximum in b represents 100-150 cells analyzed for one of triplicate samples per 438 
condition. Bars in c represent mean ± s.d. of triplicate samples (100-150 cells analyzed per 439 
sample). Similar results were observed in three independent experiments. Both analyses were 440 
performed for similar fluorescence microscopy experiments in Figs. 1, 3, and Extended Data 441 
Figs. 1, 3, 4, 8, 9, 10, and only bar graphs are shown. d, Western blot analyses of indicated 442 
proteins in HeLa/GFP-LC3 cells treated with NC or ATG7 siRNA for 72 h as in a-c. e-g, 443 
Representative western blot detection (e) and quantitation (f, g) of indicated proteins in lysates 444 
(prepared with Triton X-100 lysis buffer) of HeLa cells mock-infected or infected with SIN or 445 
HSV-1ΔBBD (MOI = 10 and 5, respectively; 7 h) with the presence or absence of Baf A1 (100 446 
nM) for 2 h (from 5 hours post infection [hpi] to 7 hpi). Bars in f and g represent mean ± s.d. of 447 
LC3-II/LC3-I ratios (f) and p62/actin ratios (g) of three independent experiments, respectively. 448 
h, i, Representative western blot detection (h) and quantitation (i) of p62 and actin in lysates 449 
(prepared with SDS lysis buffer) of HeLa cells mock-infected or infected with SIN or HSV-450 
1ΔBBD (MOI = 10 and 5, respectively; 7 h). Bars in i represent mean ± s.d. of p62/actin ratios of 451 
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three independent experiments. j, Quantitation of GFP-LC3 puncta in HeLa/GFP-LC3 cells 452 
treated with NC or ATG13 siRNA for 72 h and then mock-infected or infected with SIN or HSV-453 
1ΔBBD (MOI = 10 and 5, respectively; 4.5 h). k, Western blot analyses of indicated proteins in 454 
HeLa/GFP-LC3 cells treated with NC or ATG13 siRNA for 72 h as in j. l, Quantitation of GFP-455 
LC3 puncta in HeLa/GFP-LC3 cells mock-infected or infected with SIN or HSV-1ΔBBD (MOI 456 
= 10 and 5, respectively; 4.5 h) and treated with PIK-III (5 μM), Baf A1 (100 nM) or DMSO 457 
control for 1 h (from 3.5 hpi to 4.5 hpi). Bars in j and l represent mean ± s.d. of triplicate samples 458 
(100-150 cells analyzed per sample). Similar results were observed in three independent 459 
experiments. Unpaired two-tailed t-tests were used to compare means of Baf A1- versus DMSO-460 
treated cells, those of ATG13 siRNA- versus NC-treated cells, and those of PIK-III- versus 461 
DMSO-treated cells. One-way ANOVA with Dunnett’s test for multiple comparisons was used 462 
to compare means of SIN or HSV-1ΔBBD infection versus mock infection. For gel source data, 463 
see Supplementary Fig. 1. 464 
 465 
Extended Data Fig. 2. Schematic summary, statistical analyses and functional enrichment 466 
analyses of genome-wide siRNA screens. a, Flowchart summary of primary and deconvolution 467 
siRNA screens in HeLa/GFP-LC3 cells. Three filters were applied in the primary siRNA screens: 468 
(1) absence of cytotoxicity of siRNA pools in transfected cells; (2) lack of effect of siRNA pools 469 
on numbers of GFP-LC3 puncta in mock-infected cells (basal autophagy); and (3) significant 470 
reduction of numbers of GFP-LC3 puncta in cells infected with either SIN or HSV-1ΔBBD 471 
(virus-induced autophagy). In the deconvolution siRNA screens, positive hits were defined as 472 
those genes with two or more individual siRNA oligonucleotides from siRNA pools that 473 
reproduced the phenotype of the siRNA pools. b-d, Ranked distribution of median scores for 474 
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each siRNA pool in primary siRNA screens. Dots shown in graphs denote median scores of 475 
GFP-LC3 puncta in mock-infected cells (b), SIN-infected cells (c) and HSV-1ΔBBD-infected 476 
cells (d). e, A representative receiver operating characteristic (ROC) curve of quality control 477 
plates for primary and deconvolution screens. The ROC mean ± s.d. of all the quality control 478 
plates was 0.97 ± 0.03, which indicates accuracy and specificity in the identification of cellular 479 
factors that regulate numbers of GFP-LC3 puncta. f, Scatter plot of median scores of 216 480 
confirmed hits from the deconvolution siRNA screens (open circles) and 40 negative on-plate 481 
controls (open triangles). Scores are medians from triplicate assay plates of four individual 482 
siRNA oligonucleotides per gene. The 216 confirmed hits and 40 negative on-plate controls fall 483 
into two distinct clusters. g, Gene list from deconvolution screens for virus-induced autophagy 484 
during infection with Sindbis virus (S) and HSV-1ΔBBD (H). Numbers denote number of 485 
individual siRNA oligonucleotides that scored positive in each screen. Green, genes with 2 or 486 
more positive siRNA oligonucleotides (confirmed hits); magenta, genes with <2 positive siRNA 487 
oligonucleotides (non-confirmed hits). h, Enrichment analyses of gene sets including molecular 488 
function, biological process, cellular component and protein domain categories (terms) from 489 
DAVID Bioinformatics Resources. There were 174 terms (open triangles) that contain at least 490 
two confirmed hits and have hypergeometric test P-values less than 0.05; fourteen of these terms 491 
exhibited false discovery rate (FDR) adjusted P-values less than 0.05. The enrichment score was 492 
defined as -log10 (hypergeometric test P-value). i, Fourteen highly enriched terms plotted as a 493 
network graph. Each node represents a gene set from a variety of categories (indicated in 494 
brackets) as follows: G, GOTERM; I, INTERPRO; P, PIR_SUPERFAMILY, U, 495 
UP_SEQ_FEATURE. The size of each node corresponds to the number of confirmed siRNA hits 496 
and the color intensity is scaled according to the enrichment score. The thickness and color 497 
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intensity of lines connecting two nodes correspond to the extent of overlapping genes between 498 
two gene sets. See Fig. 1a and Supplementary Tables 1 to 5 for further details. 499 
 500 
Extended Data Fig. 3. Impaired autophagy induction by acid-mediated bypass of endocytic 501 
viral entry, confirmation of indicated gene knockdown in HeLa cells, and requirement for 502 
SNX5 in autophagy induced by diverse viruses. a, b, Representative fluorescent micrographs 503 
(a) and quantitation (b) of GFP-LC3 puncta in HeLa/GFP-LC3 cells that were either mock-504 
infected or infected with SIN or HSV-1ΔBBD (MOI = 50 and 25, respectively; 4.5 h) in the 505 
presence (pH 5.4) or absence (pH 7.4) of an acidic pulse (that induces viral entry at the plasma 506 
membrane) after viral attachment. Arrows in a denote representative GFP-LC3 puncta that 507 
would be scored as positive in b. Scale bars, 20 μm. Bars in b represent mean ± s.d. of triplicate 508 
samples (100-150 cells analyzed per sample). c, d, Viral entry efficiency in HeLa/GFP-LC3 cells 509 
treated similarly as in a and b. Bars in c and d represent mean ± s.d. of SIN minus-strand RNA 510 
levels (c) and HSV-1 immediate early gene ICP27 mRNA levels (d) of triplicate samples at 511 
indicated time points, respectively. e, Representative fluorescent micrographs of GFP-LC3 512 
puncta in HeLa/GFP-LC3 cells that were treated with indicated siRNAs (72 h) and then either 513 
mock-infected or infected with indicated virus for 4.5 h (MOI = 10 for SIN, Zika virus, WNV, 514 
CHIKV and IAV; MOI = 5 for HSV-1ΔBBD; and MOI = 20 for poliovirus and CVB3). Scale 515 
bars, 20 μm. Arrows in e denote representative GFP-LC3 puncta that would be scored as positive 516 
in Fig. 1b. f-i, Confirmation of gene knockdown in indicated siRNA-treated HeLa/GFP-LC3 517 
cells (72 h) by western blot analyses of indicated proteins (f-h) or quantitative real-time PCR of 518 
SNX32 (i) for the experiment shown in Fig. 1b. Bars in i represent mean ± s.d. of triplicate 519 
samples. j, Western blot detection of SNX5 and actin in wild-type HeLa/GFP-LC3 cells (WT), 520 
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HeLa SNX5KO/GFP-LC3 cells (KO), and two clones of reconstituted HeLa SNX5KO/GFP-521 
LC3/SNX5 cells used in the experiment shown in k. In b, one-way ANOVA with Dunnett’s test 522 
for multiple comparisons was used to compare means of SIN or HSV-1ΔBBD infection versus 523 
mock infection. In b-d, unpaired two-tailed t-tests were used to compare means of pH7.4 versus 524 
pH5.4 conditions. For e-h, j, similar results were observed in three independent experiments. In 525 
i, an unpaired two-tailed t-test was used to compare means of NC versus SNX32 knockdown. k, 526 
GFP-LC3 puncta in reconstituted HeLa SNX5KO/GFP-LC3 cells mock-infected or infected with 527 
SIN or HSV-1ΔBBD (MOI = 10 and 5, respectively; 4.5 h). Bars represent mean ± s.d. of three 528 
independent replicates (100-150 cells per sample). P-values, one-way ANOVA with Dunnett's 529 
test for multiple comparisons. For gel source data, see Supplementary Fig. 1. 530 
 531 
Extended Data Fig. 4. SNX5 is dispensable for general autophagy or non-canonical forms 532 
of autophagy that require LC3 recruitment to endolysosomal or phagosomal compartments 533 
in HeLa cells. a, b, Representative fluorescent micrographs (a) and quantitation (b) of GFP-LC3 534 
puncta in HeLa/GFP-LC3 cells that were treated with indicated siRNA (72 h) and then cultured 535 
in normal medium (1 h), starvation medium (EBSS; 1 h), or normal medium containing torin 1 536 
(250 nM; 1 h). Scale bars, 20 μm. Arrows denote representative autophagosomes that would be 537 
scored as positive in b. c, Quantitation of GFP-LC3 puncta in wild-type HeLa/GFP-LC3 cells 538 
(WT), HeLa SNX5KO/GFP-LC3 cells (KO), and two clones of reconstituted HeLa SNX5KO/GFP-539 
LC3/SNX5 cells that were cultured in normal medium (1 h), starvation medium (EBSS; 1 h), or 540 
normal medium containing torin 1 (250 nM; 1 h). d, e, Representative fluorescent micrographs 541 
(d) and quantitation (e) of wild-type HeLa/GFP-LC3 cells and HeLa SNX5KO/GFP-LC3 cells 542 
bearing Group A Streptococcus-containing autophagosome-like vacuoles (GcAVs) at 2 h post 543 
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bacterial infection (MOI = 100) with Group A Streptococcus strain JRS4 and the isogenic mutant 544 
JRS4ΔSLO (which does not induce formation of GcAVs due to defective bacterial escape from 545 
endosomes). Cellular and bacterial DNA was stained with DAPI. Boxed areas are magnified by 546 
four-fold to show micrographs of indicated channels and representative GcAVs (white puncta). 547 
Scale bars, 20 μm. f, g, Representative fluorescent micrographs (f) and quantitation (g) of wild-548 
type HeLa/GFP-LC3 cells and HeLa SNX5KO/GFP-LC3 cells undergoing non-canonical 549 
autophagy after being cultured in either normal medium or hypotonic medium for 1 h. Boxed 550 
areas are magnified by two-fold to show micrographs of individual channels. Scale bars, 20 μm. 551 
h, i, Representative differential interference contrast (DIC) microscopy and fluorescence 552 
microscopy micrographs (h) and quantitation (i) of monensin-driven LC3-associated 553 
phagocytosis (LAP) of latex beads in wild-type HeLa/GFP-LC3 cells and HeLa SNX5KO/GFP-554 
LC3 cells that were treated with monensin (100 μM) and polybead microspheres (3 μm in 555 
diameter) for 1 h. Boxed areas are magnified by nine-fold to show micrographs of DIC channel 556 
and GFP channel. Scale bars, 20 μm. In b, c, e, g and i, bars represent mean ± s.d. of triplicate 557 
samples (100-150 cells analyzed per sample). P-values were determined with one-way ANOVA 558 
with Dunnett’s test for multiple comparisons (b and c) or unpaired two-tailed t-test (e, g and i). 559 
For a, d, f, and h, similar results were observed in three independent experiments. 560 
 561 
Extended Data Fig. 5. SNX5 is not required for retromer function and endolysosomal 562 
function in HeLa cells. a, b, Representative fluorescent micrographs (a) and quantitation (b) of 563 
GLUT1 colocalized with the lysosomal marker LAMP1 in HeLa cells treated with indicated 564 
siRNA (72 h). Colocalized GLUT1 and LAMP1 puncta (yellow) represent lysosomal 565 
localization of mis-sorted GLUT1 which increases when retromer function is defective. Scale 566 
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bars, 20 μm. Bars in b represent mean ± s.d. of Manders’ overlap coefficient of GLUT1 and 567 
LAMP1 of four replicates. c-f, Confirmation of gene knockdown in indicated siRNA-treated 568 
HeLa cells (72 h) for experiments shown in a and b by western blot analyses of indicated 569 
proteins (c-e) or quantitative real-time PCR of SNX32 (f). Bars in f represent mean ± s.d. of 570 
triplicate samples. Similar results were observed in three independent experiments. g, Western 571 
blot detection of SNX5 and actin in HeLa SNX5KO cells and parental wild-type (WT) HeLa cells. 572 
h, i, Quantitation of remaining protein levels of internalized plasma membrane-anchored 573 
transferrin receptor (TfnR) in WT and SNX5KO HeLa cells during fast (h) and slow (i) endocytic 574 
recycling processes. j, k, Representative western blot analysis (j) and densitometry analysis (k) 575 
of epidermal growth factor receptor (EGFR) and actin in WT and SNX5KO HeLa cells at 576 
indicated chase time after treating with EGF (100 ng/mL). Symbols in h, i and k represent mean 577 
± s.d. of three independent experiments. P-values were determined with one-way ANOVA with 578 
Dunnett’s test for multiple comparisons (b), unpaired two-tailed t-test (f) or repeated measures 579 
ANOVA (h, i and k). For a, c-e, g, and j, similar results were observed in three independent 580 
experiments. For gel source data, see Supplementary Fig. 1. 581 
 582 
Extended Data Fig. 6. SNX5 restricts viral infection in HeLa cells and primary mouse 583 
embryonic fibroblasts (MEFs) via an autophagy-dependent mechanism. a-d, Viral 584 
infectivity assay in WT and SNX5KO HeLa cells infected with indicated virus. e-h, Viral multi-585 
step growth curves (MOI = 0.01) of WT and SNX5KO HeLa cells infected with indicated virus. i-586 
l, Viral multi-step growth curves (MOI = 0.01) of Snx5+/+ and Snx5-/- primary MEFs infected 587 
with indicated virus. m, n, Viral infectivity assay in WT and SNX5KO HeLa cells infected with 588 
autophagy-suppressive viral strains, SIN.dnAtg5 and HSV-1ΔBBD-MR. o-r, Viral multi-step 589 
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growth curves (MOI = 0.01) of WT and SNX5KO HeLa cells (o, p) and Snx5+/+ and Snx5-/- 590 
primary MEFs (q, r) infected with SIN.dnAtg5 (o, q) and HSV-1ΔBBD-MR (p, r). In a-d, m 591 
and n, bars represent mean ± s.d. of the number of viral plaques formed in cell monolayers of 592 
three replicates. In e-l and o-r, symbols represent mean ± s.d. of viral titer of three replicates. s, t, 593 
Viral entry efficiency in WT and SNX5KO HeLa cells that were infected with SIN (MOI = 50) or 594 
HSV-1ΔBBD (MOI = 25). Bars in s and t represent mean ± s.d. of SIN minus-strand RNA levels 595 
(s) and HSV-1 immediate early gene ICP27 mRNA levels (t) of triplicate samples at indicated 596 
time point, respectively. u, v, Quantitative real-time PCR analyses of relative mRNA levels of 597 
interferon beta (IFN-β; u) and the interferon-stimulated gene (ISG) interferon induced protein 598 
with tetratricopeptide repeats 1 (IFIT1; v) in WT and SNX5KO HeLa cells that were mock-599 
infected or infected with SIN or HSV-1ΔBBD (MOI = 10 and 5, respectively; 4.5 h). w, 600 
Quantitative real-time PCR analyses of relative mRNA levels of SNX5 in WT HeLa cells that 601 
were infected similarly as in u and v. In u-w, bars represent mean ± s.d. of three replicates. P-602 
values were determined with unpaired two-tailed t-test (a-d, m, n, s and t), repeated measures 603 
ANOVA (e-l and o-r) or one-way ANOVA with Dunnett’s test for multiple comparisons (u-w). 604 
Similar results were observed in three independent experiments. 605 
 606 
Extended Data Fig. 7. CNS viral titers, neuronal cell death and animal survival of virally-607 
infected Snx5+/+ and Snx5-/- littermate mice. a-c, CNS viral titers (a) and neuronal cell death 608 
(b, c) in seven-day-old Snx5+/+ (n = 8) and Snx5-/- (n = 8) littermate mice at indicated time point 609 
after infection via intracerebral (i.c.) inoculation with SIN strain dsTE12Q (1,000 pfu/mouse). d-610 
f, CNS viral titers (d) and neuronal cell death (e, f) in eight- to ten-week-old Snx5+/+ (n = 8) and 611 
Snx5-/- (n = 8) littermate mice at indicated time point after infection via i.c. inoculation with 612 
 
 28
HSV-1ΔBBD (50,000 pfu/mouse). In b and e, shown are representative micrographs of TUNEL 613 
staining of mouse brain sections from cerebral cortex (b) or basal ganglia (e) at indicated time 614 
point. Scale bars, 100 μm. Arrowheads denote representative TUNEL-positive foci that would be 615 
scored as positive in c and f. In a, c, d and f, each data point represents an individual mouse and 616 
black horizontal lines represent median values. g, Kaplan-Meier survival curve of eight- to ten-617 
week-old Snx5+/+ and Snx5-/- littermate mice infected i.c. with the autophagy-suppressive strain 618 
HSV-1ΔBBD-MR (500 pfu/mouse). Results represent combined survival data for three 619 
independent infection experiments. Similar results were observed in each independent infection. 620 
P-values were determined with unpaired two-tailed t-test (a, c, d and f) or two-sided log-rank 621 
test (g). 622 
 623 
Extended Data Fig. 8. Autophagy inhibition by PIK-III in baseline conditions, starvation 624 
and mTOR inhibition; western blot analysis of bacterially-purified SNX5 proteins; and 625 
bioinformatic analyses of SNX5 amino-acid sequences (related to Fig. 2). a-c, Representative 626 
western blots (a) and densitometry analyses (b, c) of indicated proteins in WT HeLa cells 627 
cultured in normal media in the presence or absence of PIK-III (5 μM) for 1 h. Bars in b and c 628 
represent mean ± s.d. of total LC3/actin ratios (b) and p62/actin ratios (c) of three replicates. d, e, 629 
Representative fluorescent micrographs (d) and quantitation (e) of GFP-LC3 puncta in 630 
HeLa/GFP-LC3 cells that were cultured in normal medium (1 h), starvation medium (EBSS; 1 631 
h), or normal medium containing torin 1 (250 nM; 1 h) in the presence or absence of PIK-III (5 632 
μM; 1 h) and Baf A1 (100 nM; 1h). Scale bars, 20 μm. Arrows denote representative 633 
autophagosomes that would be scored as positive in e. Bars in e represent mean ± s.d. of three 634 
replicates (100-150 cells analyzed per sample). In b, c and e, unpaired two-tailed t-test was used 635 
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to compare means of PIK-III- versus DMSO-treated cells. In e, one-way ANOVA with 636 
Dunnett’s test for multiple comparisons was used to compare means of starvation or torin 1 637 
treatment versus normal condition. f, Western blot analysis of His-tagged SUMO, SUMO-SNX5 638 
or SUMO-SNX5 EEE that were used in the experiments shown in Fig. 2c-i. For gel source data, 639 
see Supplementary Fig. 1. For a, d, and f, similar results were observed in three independent 640 
experiments. g, Amino acid sequence alignment of human SNX5 amino acids 298-361 (within 641 
the BAR domain) with the homologous regions of Snx5 proteins from eight other vertebrate 642 
animals using Cluster Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/). Grey box highlights a 643 
highly conserved region across nine vertebrate SNX5 homologs. h, Amino acid sequence 644 
alignment of human retromer-related sorting nexins. Black arrowheads denote three positively 645 
charged residues (K429, K430 and R431) in human SNX1 for which triple mutations to glutamic 646 
acid residues (SNX1 EEE) lead to the inability of SNX1 to associate to membranes and induce 647 
membrane remodeling33. In g and h, red dots indicate the residues of a positively charged stretch 648 
(K328, R330 and K332) in human SNX5 that corresponds to amino acids K429, K430, and R431 649 
in SNX1. The three residues in SNX5 (K328, R330 and K332) were substituted with glutamic 650 
acid residues to generate the SNX5 EEE mutant used in this study. Hyphens (-) denote gaps in 651 
the indicated sequence identified by sequence alignment. Asterisks (*) indicate positions with a 652 
fully conserved residue; colons (:) indicate conserved positions between groups of strongly 653 
similar properties (scoring > 0.5 in the Gonnet PAM 250 matrix); periods (.) indicate conserved 654 
positions between groups of weakly similar properties (scoring equal to or < 0.5 in the Gonnet 655 
PAM 250 matrix). Magenta cylinders represent predicted discontinued alpha helixes using the 656 
University College London (UCL) PSIPRED Protein Sequence Analysis Workbench 657 
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(http://bioinf.cs.ucl.ac.uk/psipred/). Solid line indicates a turn conformation in the tip region of 658 
the SNX1 and SNX5 BAR domains38.  659 
 660 
Extended Data Fig. 9. SNX5 is required for formation of PI3P probe puncta and WIPI2 661 
puncta during viral infection, but not in baseline conditions, or upon autophagy induction 662 
by starvation or mTOR inhibition. a-d, Representative fluorescent micrographs (a, c) and 663 
quantitation (b, d) of PI3P probe staining (a, b) or WIPI2 immunostaining (c, d) in indicated 664 
HeLa cells that were either mock-infected or infected with SIN or HSV-1ΔBBD (MOI = 10 and 665 
5, respectively; 4 h). e-h, Representative fluorescent micrographs (e, g) and quantitation (f, h) of 666 
PI3P probe staining (e, f) or WIPI2 immunostaining (g, h) in indicated HeLa cells cultured in 667 
normal medium (1 h), starvation medium (EBSS; 1 h), or normal medium containing torin 1 (250 668 
nM; 1 h). Scale bars, 20 μm. In a, c, e and g, arrows denote representative PI3P probe puncta or 669 
WIPI2 puncta that would be scored as positive in b, d, f and h. In c and g, representative cells are 670 
outlined by dashed white lines and boxed areas are magnified by sixteen-fold in the insets. In b, 671 
d, f and h, bars represent mean ± s.d. of three replicates (100-150 cells analyzed per sample). In 672 
b, d, f and h, P-values were determined by one-way ANOVA with Dunnett’s test for multiple 673 
comparisons. i, Western blot analyses of SNX5 and actin in parental wild-type HeLa cells (WT) 674 
and HeLa SNX5KO cells (KO) reconstituted with either empty vector (WT + vector and KO + 675 
vector), wild-type SNX5 (KO + SNX5) or SNX5 EEE mutant (KO + SNX5 EEE). For a, c, e, g, 676 
and i, similar results were observed in three independent experiments. For gel source data, see 677 




Extended Data Fig. 10. SNX5 is not required for virus-induced endosomal localization of 680 
PI3KC3-C1 complexes, and PI3KC3 is required for virus-induced formation of PI3P probe 681 
puncta and WIPI2 puncta in HeLa cells. a, Representative fluorescent micrographs of 682 
indicated immunostaining in parental wild-type and SNX5KO HeLa cells that were either mock-683 
infected or infected with SIN and HSV-1ΔBBD (MOI = 10 and 5, respectively; 2 h). Scale bars, 684 
20 μm. Boxed areas are magnified by four-fold in the insets. b-e, Representative fluorescent 685 
micrographs (b and d) and quantitation (c and e) of PI3P probe staining (b, c) or WIPI2 686 
immunostaining (d, e) in HeLa cells that were either mock-infected or infected with SIN or 687 
HSV-1ΔBBD (MOI = 10 and 5, respectively; 4 h) and treated for 1 h with PIK-III (5 μM) or 688 
DMSO control prior to fixation (from 3 hpi to 4 hpi). Scale bars, 20 μm. Arrows in b and d 689 
denote representative PI3P probe puncta and WIPI2 puncta that would be scored as positive in c 690 
and e, respectively. In d, representative cells are outlined by dashed white lines and boxed areas 691 
are magnified by sixteen-fold in the insets. Bars in c and e represent mean ± s.d. of three 692 
replicates (100-150 cells analyzed per sample). In c and e, unpaired two-tailed t-test was used to 693 
compare means of PIK-III- versus DMSO-treated cells, and one-way ANOVA with Dunnett’s 694 
test for multiple comparisons was used to compare means of SIN or HSV-1ΔBBD infection 695 
versus mock infection. For a, b, and d, similar results were observed in three independent 696 
experiments.  697 




Mammalian cell lines and cell culture 700 
All cell culture reagents including media, sera, antibiotics and trypsin-EDTA (0.25%), were 701 
purchased from Invitrogen/Gibco (Thermo Fisher Scientific) unless otherwise specified. Primary 702 
mouse embryonic fibroblasts (MEFs) were isolated from Snx5+/+ and Snx5-/- littermate offspring 703 
on embryonic day (E) 13.5 as previously described39. HeLa, BHK-21, Vero and 293T cell lines 704 
were obtained from American Type Culture Collection (ATCC), which have been thoroughly 705 
tested and authenticated by ATCC. Additional authentication of HeLa cells was performed by 706 
the ATCC Cell Line Authentication Service using short-tandem repeat profiling (STR) analysis. 707 
Vero E6 cell line was a gift from Matthew B. Frieman (University of Maryland), which 708 
originally sourced from ATCC (CRL-1586) and was not further authenticated. MDCK cell line 709 
was a gift from Charles M. Rice (The Rockefeller University), which was authenticated as canine 710 
origin by cloning and sequencing immune genes from stimulated cells. HEK293F cell line was a 711 
gift from Hongwei Wang (Tsinghua University). All the cell lines used in this study tested 712 
negative for mycoplasma contamination using PCR-based Venor GeM Mycoplasma Detection 713 
Kit (Sigma-Aldrich MP0025). All the cell lines were cultured and maintained according to 714 
ATCC’s instructions, and used at low passage numbers. HeLa cell clones were cultured in Opti-715 
MEM I Reduced Serum Medium supplemented with 5% fetal bovine serum (FBS), 100 units/mL 716 
penicillin and 100 μg/mL streptomycin. MEFs, BHK-21 cells, Vero cells, Vero E6 cells, MDCK 717 
cells and HEK293T cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) 718 
supplemented with 10% FBS, 100 units/mL penicillin and 100 μg/mL streptomycin. Media 719 
supplemented with heat-inactivated (HI) FBS were used for viral infection experiments. 720 
HEK293F cells were cultured in SMM293-TI medium (Sino Biological) supplemented with 100 721 
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units/mL penicillin and 100 μg/mL streptomycin. HeLa/GFP-LC3 cells that stably express GFP-722 
LC3 were generated by transfecting HeLa cells with a plasmid pIRES.GFP-LC3.neo3 and 723 
selection in medium containing 500 ng/mL geneticin. HeLa SNX5 CRISPR knockout cell lines 724 
(HeLa SNX5KO) were generated by CRISPR/Cas9-induced double-strand break at the Genome 725 
Engineering and iPSC Center (GEiC) of Washington University School of Medicine (St. Louis, 726 
MO). Sequences encompassing candidate guide RNA (gRNA) sites were analyzed for common 727 
(>1%) single nucleotide polymorphisms (SNPs) using the UCSC Genome Browser 728 
(https://genome.ucsc.edu), and no common SNPs were detected in the selected two gRNAs for 729 
the target gene. The sequences of gRNAs used for CRISPR knockout are as follows: SNX5 730 
exon5.g7: 5’-CCGCTGAAGAAAGACTTCATNGG-3’ and SNX5 exon5.g8: 5’-731 
CTGAAGAAAGACTTCATGGGNGG-3’. Frequencies of local insertions and deletions (indels) 732 
in a SNX5 CRISPR knockout clone were determined using targeted deep sequencing, which 733 
confirmed the gRNA-targeted SNX5 deletion in the HeLa cell genome. Reconstituted HeLa 734 
SNX5KO/SNX5 cells, HeLa SNX5KO/SNX5 EEE cells, HeLa SNX5KO/vector cells, and HeLa 735 
WT/vector control cells were generated by infection with retroviruses expressing wild-type 736 
human SNX5, SNX5 EEE mutant (K328E/R330E/K332E; Extended Data Fig. 8g, h), or an 737 
empty vector, which was followed by selection in medium containing 500 ng/mL puromycin. 738 
HeLa SNX5KO/GFP-LC3 cells were generated by transfecting HeLa SNX5KO cells with a plasmid 739 
pIRES.GFP-LC3.neo3 and selection in medium containing 500 ng/mL geneticin. Reconstituted 740 
HeLa SNX5KO/GFP-LC3/SNX5 cells were generated by transfecting HeLa SNX5KO/GFP-LC3 741 
cells with a plasmid pIRES.SNX5.puro3 and selection in medium containing 500 ng/mL 742 
puromycin. For viral infection experiments using the stable cell lines described above, selection 743 
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antibiotics (such as geneticin or puromycin) were withdrawn from the culture media for at least 744 
24 h prior to viral infection. 745 
Mouse strains 746 
C57BL/6J mice were obtained from The Jackson Laboratory and all mouse strains used in this 747 
study were backcrossed to female C57BL/6J breeders for more than ten generations. Snx5-/- mice 748 
were generated by the UC DAVIS Knockout Mouse Project (KOMP) Repository 749 
(https://www.komp.org/) and have been previously described23. Genomic DNA from mice was 750 
prepared from mouse tail using DirectPCR Lysis Reagent (Viagen Biotech) and Proteinase K 751 
(Roche). Mouse genotypes were determined by PCR using TaKaRa SapphireAmp Fast PCR 752 
Master Mix (Clontech) and the following primer pairs: Snx5 WT-1, 5’-753 
GCTTTGCCTCTGATTTGGATCTCC-3’; Snx5 WT-2, 5’-754 
CTAAGACAATAAAACCCACCGGGCG-3’; Snx5 KO-1, 5’-755 
GACATGAGCACACTGTTAGTGCAGG-3’; Snx5 KO-2, 5’-756 
GAGATGGCGCAACGCAATTAATG-3’. The PCR conditions are as follows: 1 min at 94, 35 757 
cycles of amplification stage (5 sec at 98, 5 sec at 55 and 5 sec at 72) and 5 min at 72. 758 
Snx5+/+ genomic DNA yields a 405-bp band; Snx5-/- genomic DNA yields a 386-bp band; Snx5+/- 759 
genomic DNA yields both a 405-bp band and a 386-bp band. 760 
Chemicals 761 
Bafilomycin A1 (Baf A1; Sigma-Aldrich B1793), a lysosomal inhibitor, was dissolved in sterile-762 
filtered DMSO (Sigma-Aldrich D2650) as a 100 μM stock solution. Cycloheximide (Sigma-763 
Aldrich C7698) was dissolved in sterile water as a 10 mg/mL stock solution and then passed 764 
through a 0.22-μm filter. Monensin (Sigma-Aldrich M5273) was dissolved in ethanol (Thermo 765 
Fisher Scientific) as a 50 mg/mL (72.2 mM) stock solution. PIK-III (Selleck Chemicals S7683), 766 
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a PI3KC3 (VPS34)-specific inhibitor40, was dissolved in sterile-filtered DMSO as a 4 mM stock 767 
solution. Torin 1 (Selleck Chemicals S2827), an mTOR inhibitor41, was dissolved in sterile-768 
filtered DMSO as a 1 mM stock solution. All stock solutions were stored in small aliquots at -769 
20. For control groups of chemical treatment, equivalent volume of according chemical-free 770 
sterile solvent was added into culture media. 771 
Antibodies  772 
The following commercial antibodies (vendor, catalog number and dilution) were used for 773 
immunoprecipitation, western blot analyses and immunofluorescence staining according to 774 
manufacturers’ instructions: mouse anti-actin monoclonal antibody (Sigma-Aldrich A1978, 775 
1:1000), mouse anti-actin monoclonal antibody (C4) HRP (Santa Cruz Biotechnology sc-47778 776 
HRP, 1:5000), rabbit anti-ATG7 polyclonal antibody (Sigma-Aldrich A2856, 1:1000), rabbit 777 
anti-ATG13 monoclonal antibody (Abcam ab201467, 1:2000), mouse anti-ATG14 monoclonal 778 
antibody (MBL International Corporation M184-3, 1:500 for western blot and 1:1000 for 779 
immunofluorescence staining), rabbit anti-ATG14 polyclonal antibody (Cell Signaling 780 
Technology 5504S, 1:500), mouse anti-beclin 1 monoclonal antibody (E-8) (Santa Cruz 781 
Biotechnology sc-48341, 1:1000 for western blot and 1:100 for immunoprecipitation), rabbit 782 
anti-beclin 1 polyclonal antibody (H-300) (Santa Cruz Biotechnology sc-11427, 1:1000), goat 783 
anti-EEA1 polyclonal antibody (N-19) (Santa Cruz Biotechnology sc-6415, 1:200), rabbit anti-784 
EEA1 polyclonal antibody (H-300) (Santa Cruz Biotechnology sc-33585, 1:200), rabbit anti-785 
EGFR monoclonal antibody (Cell Signaling Technology 4267S, 1:1000), rabbit anti-GLUT1 786 
polyclonal antibody (Abcam ab15309, 1:500), mouse 6×-His tag monoclonal antibody (HIS.H8) 787 
(Thermo Fisher Scientific MA1-21315, 1:500), goat anti-LAMP1 polyclonal antibody (C-20) 788 
(Santa Cruz Biotechnology sc-8098, 1:200), rabbit anti-LC3B polyclonal antibody (Novus 789 
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Biologicals NB100-2220, 1:2000), guinea pig anti-p62/SQSTM1 (C-terminus) polyclonal serum 790 
(Progen GP62-C, 1:1000), mouse anti-p62/SQSTM1 monoclonal antibody (Abnova H00008878-791 
M01, 1:5000), goat anti-SNX5 polyclonal antibody (Abcam ab5983, 1:100 for both 792 
immunoprecipitation and western blot), mouse anti-SNX5 monoclonal antibody (F-11) (Santa 793 
Cruz Biotechnology sc-515215, 1:400 for western blot and 1:200 for immunofluorescence 794 
staining), rabbit anti-UVRAG monoclonal antibody (D2Q1Z) (Cell Signaling Technology 795 
13115, 1:500), rabbit anti-UVRAG polyclonal antibody (Sigma-Aldrich U7508, 1:1000), rabbit 796 
anti-VPS29 polyclonal antibody (Abcam ab98929, 1:500), rabbit anti-VPS34 monoclonal 797 
antibody (D9A5) (Cell Signaling Technology 4263S, 1:100 for western blot and 1:200 for 798 
immunofluorescence staining), mouse anti-WIPI2 monoclonal antibody (Bio-Rad Laboratories 799 
MCA5780GA, 1:200), normal goat IgG (Abcam ab37373, 1:1000), normal mouse IgG (Santa 800 
Cruz Biotechnology sc-2025, 1:200), donkey anti-goat IgG-HRP (Santa Cruz Biotechnology sc-801 
2056, 1:1000), goat anti-guinea pig IgG H&L (HRP) (Abcam ab6908, 1:2000), peroxidase 802 
AffiniPure goat anti-mouse IgG Fcγ fragment specific antibody (Jackson ImmunoResearch 803 
Laboratories 115-035-071, 1:2000), donkey anti-rabbit IgG HRP-conjugate species-adsorbed 804 
(EMD Millipore AP182P, 1:2000), donkey anti-goat IgG (H+L) cross-adsorbed secondary 805 
antibody Alexa Fluor 594 (Thermo Fisher Scientific A11058, 1:1000), donkey anti-goat IgG 806 
(H+L) cross-adsorbed secondary antibody Alexa Fluor 647 (Thermo Fisher Scientific A-21447, 807 
1:1000), donkey anti-mouse IgG (H+L) highly cross-adsorbed secondary antibody Alexa Fluor 808 
488 (Thermo Fisher Scientific A21202, 1:1000), donkey anti-rabbit IgG (H+L) highly cross-809 
adsorbed secondary antibody Alexa Fluor 488 (Thermo Fisher Scientific A-21206, 1:1000), and 810 
donkey anti-rabbit IgG (H+L) highly cross-adsorbed secondary antibody Alexa Fluor 594 811 




Streptococcus pyogenes (also known as Group A Streptococcus) wild-type serotype M6 strain 814 
JRS4 (M6+F1+) and the isogenic mutant JRS4ΔSLO were kindly provided by Ichiro Nakagawa 815 
(Kyoto University)19. JRS4ΔSLO lacks the gene streptolysin O (SLO), a cholesterol-dependent 816 
pore-forming exotoxin, and thus does not escape from endosomes and induce Group A 817 
Streptococcus-containing autophagosome-like vacuoles (GcAVs) in HeLa cells19. Group A 818 
Streptococcus strains were amplified in BBL Brain Heart Infusion medium (Becton, Dickinson 819 
and Company) in a 5% CO2 incubator. For subcloning, Invitrogen MAX Efficiency DH5α 820 
Competent Cells (Thermo Fisher Scientific) were transformed with plasmids and selected on LB 821 
agar plates with certain selection antibiotics. Isolated single colonies were cultured in Difco 822 
Terrific Broth medium (Becton, Dickinson and Company) in an Innova 43 Incubator Shaker 823 
(New Brunswick Scientific). Bacterial plasmids for cloning experiments were amplified using a 824 
Plasmid Midi Kit (QIAGEN) and stored in -20°C. The insertion fragment in a plasmid was 825 
confirmed by Sanger sequencing. 826 
Viral strains 827 
A herpes simplex virus type 1 (HSV-1) mutant strain (HSV-1ΔBBD) was previously genetically 828 
engineered to expresses a neurovirulent factor ICP34.5 mutant that lacks the beclin 1-binding 829 
domain (BBD) and is unable to suppress autophagy5,42. A marker-rescued HSV-1 control strain 830 
(HSV-1ΔBBD-MR) expressing wild-type ICP34.5 was generated in parallel and shown to 831 
suppress autophagy in both cultured neuronal cells and brains of intracerebrally infected mice5. 832 
The Sindbis virus (SIN) strain SVIA (ATCC) was derived from a low-passage isolate of the 833 
wild-type SIN strain AR33943. In this study, the SIN strain used in the majority of cell culture 834 
infection experiments was SVIA unless otherwise specified. The recombinant SIN strain with a 835 
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double subgenomic promoter generated from the SIN vector, dsTE12Q, was previously 836 
described44, as was the recombinant SIN strain dsTE12Q.dnAtg5 (SIN.dnAtg5), which expresses 837 
a dominant negative mutant of autophagy core machinery protein, Atg5 K130R, from the second 838 
subgenomic promoter, and has been previously shown to inhibit autophagy in brains of 839 
intracerebrally infected mice6. Recombinant SIN strains, SIN.dnAtg5 and its parental wild-type 840 
control dsTE12Q, were used in animal experiments (Fig. 1c, Extended Data Fig. 7a-c) and some 841 
in vitro experiments (Extended Data Fig. 6m, o, q). The recombinant SIN strain SIN.mCherry-E2 842 
that express mCherry-fused envelope glycoprotein E2 was previously described35. The following 843 
additional viral strains were used in this study: chikungunya virus (CHIKV) strain 06-02145 (a 844 
gift from Deborah J. Lenschow, Washington University); Coxsackievirus B3 strain H3 (CVB3-845 
H3) generated from an infectious clone (a gift from Marco Vignuzzi, Pasteur Institute); influenza 846 
A virus (IAV) strain A/WSN/33 (a gift from Adolfo Garcia-Sastre, Icahn School of Medicine at 847 
Mount Sinai); poliovirus generated from the Mahoney type 1 infectious clone (a gift from Karla 848 
Kirkegaard, Stanford University); West Nile virus (WNV) strain TX0246 (a gift from Michael 849 
Gale Jr., University of Washington) for infection of HeLa cells and MEFs; WNV strain Egypt-850 
10147 (a gift from Michael S. Diamond, Washington University) for mouse infection; and Zika 851 
virus strain MR-766 (obtained from Centers for Disease Control and Prevention [CDC]). Viral 852 
stocks were propagated and titrated by plaque assays in Vero cells (for HSV-1 and CHIKV), 853 
BHK-21 cells (for SIN and WNV), Vero E6 cells (for Zika virus), HeLa cells (for poliovirus and 854 
CVB3) and MDCK cells (for IAV), respectively. 855 
Retroviruses for reconstitution of HeLa SNX5KO cell lines 856 
To generate reconstituted HeLa SNX5KO cell lines, retroviruses were constructed by co-857 
transfection of HEK293T cells with pCMV-VSV-G (Addgene plasmid #8454), pUMVC 858 
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(Addgene plasmid #8449), and pBABE-puro empty vector (Addgene plasmid #1764), pBABE-859 
puro-Flag-SNX5 or pBABE-puro-Flag-SNX5 EEE (that carries K328E/R330E/K332E triple 860 
mutations) at a mass ratio of 1:9:10 according to Addgene’s instructions. Cell culture 861 
supernatants were collected at 48 h and 72 h post transfection. Combined supernatants were pre-862 
cleared by centrifugation at 1,000 g and 4 for 15 min and then passed through sterilized 0.45-863 
μm filters (EMD Millipore). Target cells were infected with fresh media containing retroviral 864 
supernatants and 8 μg/mL polybrene (Santa Cruz Biotechnology sc-134220) for 5 h. Retrovirus-865 
containing media were then replaced with fresh virus-free medium, cultured for an additional 48 866 
h, and cells were selected in medium containing 500 ng/mL puromycin. 867 
Small interfering RNAs (siRNAs) 868 
All siRNA oligonucleotides used in this study were synthesized by Dharmacon. The high-869 
content siRNA screens used a genome-wide human siRNA library (siGENOME of Dharmacon) 870 
containing 18,115 SMARTpools, in which each pool contains four siRNA oligonucleotides 871 
targeting an individual gene. The sequences or catalog number of non-targeting control siRNAs 872 
(NC) and gene-specific siRNA oligonucleotides are as follows: NC, 5’-873 
AUCCGCGCGAUAGUACGUA-3’ and 5’-UUACGCGUAGCGUAAUACG-3’; ATG7, 5’-874 
GGGUUAUUACUACAAUGGUG-3’; ATG13, 5’-AGACCAUCUUUGUCCGAAA-3' and 5’-875 
GAAGAAUGUCCGCGAGUUU-3’; SNX5, siGENOME siRNA D-012524-01, D-012524-02, 876 
D-012524-03 and D-012524-04; SNX32, ON-TARGETplus SMARTpool L-017082-01; VPS29, 877 
ON-TARGETplus SMARTpool L-009764-01. 878 
High-content image-based genome-wide siRNA screens 879 
Primary screens: The siGENOME library siRNA pools were seeded in parallel into nine 880 
identical SensoPlate glass-bottom 96-well microplates (Greiner Bio-One 655892) in 25 μL Opti-881 
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MEM I Reduced Serum Medium at a final concentration of 50 nM using a BioMek FX Robotic 882 
Liquid Handling System (Beckman Coulter Life Sciences), followed by addition of Invitrogen 883 
Lipofectamine RNAiMAX (Thermo Fisher Scientific) in 25 μL Opti-MEM I Reduced Serum 884 
Medium at a final dilution of 1:500 with an EL406 Washer Dispenser (BioTek Instruments). 885 
siRNA oligonucleotides were incubated with Lipofectamine RNAiMAX for 30 min at room 886 
temperature, followed by addition of 6,000 HeLa/GFP-LC3 cells in 100 μL Opti-MEM I 887 
Reduced Serum Medium supplemented with 5% HI FBS, 100 units/mL penicillin and 100 888 
μg/mL streptomycin (normal medium) using a Multidrop 96/384 Microplate Dispenser (MTX 889 
Lab Systems) for reverse transfection. For all the 96-well plates, the first column and the twelfth 890 
column were used for on-plate negative and positive controls, which contained alternating wells 891 
of non-targeting control siRNAs (NC) and siRNA targeting the essential autophagy gene ATG7; 892 
and column 2 to column 11 contained siGENOME library siRNA pools (one well/plate/pool). 893 
Three sets of triplicate plates (Plate 1 to Plate 3, Plate 4 to Plate 6, and Plate 7 to Plate 9) were 894 
used for mock infection, SIN infection and HSV-1ΔBBD infection, respectively. After 48-hour 895 
siRNA knockdown, Plate 1 to Plate 3 were mock-infected by dispensing 40 μL/well of virus-free 896 
normal medium using an EL406 Washer Dispenser. For the two sets of triplicate plates used for 897 
viral infection, the first columns of Plate 4 to Plate 9 were mock-infected by dispensing 40 898 
μL/well of virus-free normal medium (on-plate mock infection controls), and column 2 to 899 
column 12 of these plates were infected by dispensing 40 μL/well of normal media containing 900 
SIN strain SVIA (at a multiplicity of infection [MOI] of 10) or HSV-1ΔBBD (MOI = 5), 901 
respectively. After 1.5-hour incubation at 37 (viral adsorption and entry), the culture media in 902 
all nine plates were replaced with 200 μL/well of fresh normal medium using an EL406 Washer 903 
Dispenser. After an additional 2.5-hour incubation at 37, 25 μL normal medium containing 904 
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Invitrogen Hoechst 33342 (Thermo Fisher Scientific) was added to each well (at a final 905 
concentration of 5 μg/mL) to stain cellular nuclei. After 20-min additional incubation at 37 906 
(approximately 4.5 hours post infection [hpi]), medium was aspirated using an EL406 Washer 907 
Dispenser and all plates were immediately fixed with 100 μL pre-warmed 3% paraformaldehyde 908 
(PFA) (Electron Microscopy Sciences) in 1× Gibco PBS containing Ca2+ and Mg2+ (Thermo 909 
Fisher Scientific) for 20 min at room temperature. The fixation solution was replaced with 1× 910 
Gibco PBS (Thermo Fisher Scientific), and all plates were sealed with Microplate Aluminum 911 
Tapes (Corning) and stored at 4 until imaging. All assay plates were imaged within three days 912 
after fixation. 913 
High-content automated imaging: Digital images were acquired with a BD Pathway 855 914 
Bioimaging System (BD Biosciences) using an Olympus UAPO/340 40× 340nm air objective 915 
(0.9 NA). The microscope filters used for imaging were: Hoechst channel (Ex: 360/10, Dichroic: 916 
400DCLP, Em: 435LP), GFP channel (Ex: 488/10, Dichroic: Fura/FITC, Em: 515LP) and wide-917 
field epifluorescence. Raw micrographs of the Hoechst channel were utilized to determine cell 918 
boundaries by a watershed segmentation method, which uses Hoechst-positive nuclei as markers 919 
and cytosolic Hoechst signal as the background. After cell segmentation, raw micrographs of the 920 
GFP channel were further analyzed to obtain numbers of subcellular GFP-LC3 puncta per cell 921 
for each micrograph using the Imaging and Advanced Imaging packages in the software Pipeline 922 
Pilot 8.5 (Accelrys). Approximately 250 to 450 cells were analyzed per well.  923 
Assessment of viral infection: To determine whether siRNA knockdown indirectly affected 924 
autophagy levels through inhibition of early stages of viral infection (e.g. attachment and 925 
uptake), 316 candidate hits from the primary screens were further examined using the same 926 
conditions as for the primary screens. Four cherry-picked siRNA library plates (96-well) were 927 
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generated using the 316 siRNA pools that scored positive in the primary screens. The assay 928 
plates were prepared similarly as for the primary screens. Instead of PFA fixation at 4.5 hpi, 929 
assay plates were immediately frozen after incubation with viral inoculum for 1.5 h (1.5 hpi) and 930 
stored at -80 for quantitation of viral loads by plaque assay titration (after three freeze-thaw 931 
cycles).  932 
Deconvolution screens: To rule out false-positive hits due to off-target effects of individual 933 
siRNA oligonucleotides, 310 candidate genes that passed primary screens were further re-934 
screened for their efficacy in decreasing the number of GFP-LC3 puncta in HeLa/GFP-LC3 cells 935 
infected with SIN and HSV-1ΔBBD. Sixteen customized Dharmacon siRNA library plates (96-936 
well) were generated with four siRNA oligonucleotides for each gene (one siRNA 937 
oligonucleotide per well). A total of forty wells of NC oligonucleotide was added in the middle 938 
of the plates (columns 2 to 11) which served as on-plate negative controls. The assay plates were 939 
prepared similarly as for the primary screens, except that individual siRNA oligonucleotides 940 
(instead of siRNA pools) were used for gene knockdown. 941 
Quality control (QC) of high-content siRNA screens: Given that 2,268 assay plates (in 35 942 
batches) were used throughout the primary and deconvolution screens, one sentinel assay plate 943 
was included for each batch of experiment to monitor batch-to-batch variation. For these sentinel 944 
assay plates, NC and siRNAs targeting ATG7 (48 wells each) were seeded in an alternating 945 
pattern on 96-well microplates. All sentinel assay plates were handled together with the set of 946 
assay plates for mock infection using the same procedure. After image acquisition and 947 
quantitation of numbers of GFP-LC3 puncta, the sensitivity and the specificity of the analysis 948 
method was evaluated based on the true positive (ATG7 siRNA) and true negative (negative 949 
control siRNA) wells. The receiver operating characteristic (ROC) curves were plotted (e.g. 950 
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Extended Data Fig. 2e), and the areas under the curves (AUC) values were calculated to evaluate 951 
the screening performance. The ROC mean ± s.d. of all the QC plates was 0.97 ± 0.03, which 952 
indicates accuracy and specificity in the identification of cellular factors that regulate numbers of 953 
GFP-LC3 puncta. 954 
Statistical analyses of siRNA screens: In the primary siRNA screens, we applied three 955 
filters: (1) absence of cytotoxicity of siRNA pools in transfected cells; (2) lack of effect of 956 
siRNA pools on numbers of GFP-LC3 puncta in mock-infected cells (basal autophagy); and (3) 957 
significant reduction of numbers of GFP-LC3 puncta in cells infected with either SIN or HSV-958 
1ΔBBD (virus-induced autophagy). siRNA pools that have at least two out of three replicate 959 
wells with cell numbers less than 100 per montage were considered to have cytotoxic effects in 960 
transfected cells and excluded from statistical analyses. To identify siRNA pools that alter only 961 
virus-induced autophagy but not basal autophagy, we then performed the following two 962 
analyses: 963 
The first analysis used a mixed-effects Poisson regression, where the number of GFP-LC3 964 
puncta in each cell serves as the response variable and the siRNA treatment (using negative 965 
control wells as references) serves as the independent variable. A random intercept was included 966 
to model the correlated observations among cells within each well. This analysis was performed 967 
independently for each of the three screens (mock infection, SIN infection and HSV-1ΔBBD 968 
infection) and for each of the triplicate plates of each screen. The coefficient value indicates the 969 
magnitude of the effect of an siRNA treatment on numbers of GFP-LC3 puncta compared to that 970 
of NC treatment, and the two-sided P-value from Wald-test indicates the statistical significance 971 
of the effect. The siRNA pools with either coefficient values greater than log(1/2) (i.e. 50% 972 
reduction) or P-values greater than 0.05 in at least two out of the three replicate mock infection 973 
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assay plates were considered as siRNA pools that do not suppress basal autophagy. The siRNA 974 
pools with coefficient values less than log(1/2) and P-values less than 0.05 in at least two out of 975 
the three replicate viral infection assay plates were considered as siRNA pools that suppress SIN-976 
induced autophagy and/or HSV-1ΔBBD-induced autophagy. The siRNA pools that specifically 977 
suppress virus-induced autophagy without suppressing basal autophagy were considered as 978 
candidate hits in this analysis. 979 
The second analysis also used a mixed-effects Poisson regression, where the number of 980 
GFP-LC3 puncta in each cell serves as the response variable. Unlike the first analysis that 981 
inspects each plate separately, this analysis used a single integrated model to analyze all nine 982 
assay plates from three screens (mock infection, SIN infection and HSV-1ΔBBD infection). 983 
Random intercepts were used to take into account correlated observations among cells in the 984 
same well or cells in different wells but in the same assay plate. In addition to the main effects of 985 
siRNA treatment and viral infections, the fixed effects also included their interactions, the 986 
coefficient values of which indicate the difference in the siRNA’s effect during viral infections 987 
compared to that during mock infection, and the two-sided P-values of the interaction terms from 988 
Wald-test indicate the statistical significance of such difference. The siRNA pools with 989 
coefficient values of the interaction term less than log(1/2) and P-values less than 0.05 were 990 
considered as candidate hits in this analysis, whose effects on virus-induced autophagy are more 991 
pronounced than on basal autophagy. 992 
Both the first analysis and the second analysis described above were performed in open-993 
source R software (www.r-project.org) version 3.1.0 with package lme4 version 1.0-4. The 994 
overlapping siRNA pools identified by both statistical analyses were considered as candidate 995 
unique hits involved specifically in virus-induced autophagy. The first analysis ensured that 996 
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scored candidate siRNA pools significantly suppressed virus-induced autophagy at the desired 997 
threshold magnitude while not suppressing basal autophagy. The second analysis further ensured 998 
that scored candidate siRNA pools led to statistically significantly greater reduction of autophagy 999 
(i.e. GFP-LC3 puncta number) during viral infection than during mock infection.  1000 
For assessing early stages of viral infection, the relative fold of viral load for each well of 1001 
the 316 overlapping siRNA pools (that were identified as candidate hits by both statistical 1002 
analyses) was normalized in reference to the median viral loads of NC-treated wells on the first 1003 
and twelfth columns for each assay plate. For each well, normalized viral loads that were either 1004 
less than 0.2 or larger than 5 were considered to represent a biologically significant effect, and 1005 
siRNA pools that altered intracellular viral loads in at least two out of three wells were 1006 
considered as siRNA pools that alter early stages of viral infection (and thereby indirectly affect 1007 
virus-induced autophagy). Six such genes were removed from the candidate list from primary 1008 
screens: ZNF224 (Entrez Gene ID: 7767), DGAT1 (Entrez Gene ID: 8694), NCOR2 (Entrez 1009 
Gene ID: 9612), IL20 (Entrez Gene ID: 50604), OTUD4 (Entrez Gene ID: 54726) and EPB41L5 1010 
(Entrez Gene ID: 57669). The remaining 310 genes were the candidate hits that pass the primary 1011 
screens. 1012 
In the deconvolution screens, we performed similar analyses for each siRNA 1013 
oligonucleotide as that for siRNA pools in the first analysis of the primary screens to assess the 1014 
effect of each siRNA oligonucleotide on SIN-induced autophagy and HSV-1ΔBBD-induced 1015 
autophagy. For each candidate gene identified by the primary screens, genes having two or more 1016 
oligonucleotides passing the deconvolution screens were considered as the confirmed hits of our 1017 
siRNA screens.  1018 
Bioinformatic analyses of confirmed hits from the deconvolution siRNA screens 1019 
 
 46
The gene identity (Entrez gene ID) of 216 confirmed siRNA screen hits was first converted to 1020 
the Universal Protein Resource (UniProt) protein knowledgebase (UniProtKB) ID using the 1021 
Retrieve/ID mapping function (http://www.uniprot.org). The gene sets were then analyzed by 1022 
DAVID Bioinformatics Resources 6.8 (https://david.ncifcrf.gov/) using the default settings, 1023 
including molecular function (MF), biological process (BP) and cellular component (CC) 1024 
categories from Gene Ontology (GOTERM), InterPro protein sequence analysis & classification 1025 
(INTERPRO), the European Bioinformatics Institute (EMBL-EBI) BioCarta Pathway 1026 
(BIOCARTA), Kyoto Encyclopedia of Genes and Genomes PATHWAY Database (KEGG), 1027 
UniProt protein knowledgebase (UP), Online Mendelian Inheritance in Man (OMIM), The 1028 
Protein Information Resource (PIR), Clusters of Orthologous Groups of proteins (COGs), Simple 1029 
Modular Architecture Research Tool (SMART) and the Biological Biochemical Image Database 1030 
(BBID)48,49. Hypergeometric tests were performed to assess the enrichment of each functional 1031 
gene set for the confirmed siRNA hits. The enrichment score was defined as -1032 
log10(hypergeometric test P-value). Enriched gene sets having false discovery rate (FDR) 1033 
adjusted P-values below 0.05 were considered as terms that were significantly enriched. All 1034 
computations were conducted in the R environment version 3.5.1 (www.r-project.org). 1035 
To construct a functional enrichment network graph, the above enrichment results were 1036 
plotted as a graph with nodes denoting enriched gene sets. The size of each node corresponds to 1037 
the number of confirmed siRNA hits and the color intensity, which is scaled according to the 1038 
enrichment score. The thickness and color intensity of lines connecting two nodes represent the 1039 
extent of overlap between two gene sets, which was calculated using the following formula: 1040 
Extent of overlap (Set A | Set B) = 
Number of overlapping genes
Number of genes in Set A + Number of genes in Set B - Number of overlapping genes
. 1041 
RNA interference in follow-up study of confirmed siRNA screen hits 1042 
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RNA interference was performed to knock down the expression of target genes in HeLa cells 1043 
cultured in either 10-cm petri dishes or 6-well plates. Cells were reverse transfected with specific 1044 
siRNA oligonucleotides using Invitrogen Lipofectamine RNAiMAX according to the 1045 
manufacturer’s instruction for 72 h. Knockdown efficiency of target genes was confirmed by 1046 
either western blot analysis or quantitative real-time PCR analysis.  1047 
Quantitative real-time PCR (qRT-PCR) analysis 1048 
Total RNA was extracted from HeLa cells using an RNeasy Plus Mini Kit (Qiagen) and further 1049 
treated with DNase I (New England Biolabs) to remove residual genomic DNA contamination. 1050 
Complementary DNA (cDNA) was synthesized using 1 μg purified RNA, oligo-dT primer and 1051 
an iScript cDNA Synthesis Kit (Bio-Rad Laboratories ). Relative gene expression levels were 1052 
assessed using QuantiFast SYBR Green PCR Kit (Qiagen) on a 7500 Fast Real-Time PCR 1053 
System (Applied Biosystems). The qRT-PCR primers for human SNX32, SNX5, IFN-β, IFIT1 1054 
and β-actin (internal control) used in this study are as follows: SNX32 forward primer, 5’-1055 
TGGCTTCCGATGAGGACCTGAA-3’; SNX32 backward primer, 5’-1056 
CCTTGTTGGCATTCTCGTAGTCG-3’; SNX5 forward primer, 5’-1057 
CAGAGCCCAGAGTTTTCTGTTAC-3’; SNX5 backward primer, 5’-1058 
CCCAGCATAGTCTGTTGTTTCA-3’; IFN-β forward primer, 5’-1059 
ATGACCAACAAGTGTCTCCTCC-3’; IFN-β backward primer, 5’-1060 
GGAATCCAAGCAAGTTGTAGCTC-3’; IFIT1 forward primer, 5’-1061 
TTGATGACGATGAAATGCCTGA-3’; IFIT1 backward primer, 5’-1062 
CAGGTCACCAGACTCCTCAC-3’; β-actin forward primer, 5’-CTGGCACCCAGCACAATG-1063 
3’; β-actin backward primer, 5’-GCCGATCCACACGGAGTACT-3’. 1064 
Assessment of viral entry 1065 
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To compare viral entry efficiency between cell lines, we used a qRT-PCR-based approach to 1066 
assess relative quantity of SIN minus strand RNA and the HSV-1 immediate early gene ICP27 1067 
transcript as their levels correlate with genomic contents of incoming virions in the 1068 
cytoplasm50,51. HeLa cells were incubated with either SIN (MOI = 50) or HSV-1ΔBBD (MOI = 1069 
25) viral inoculum (in Opti-MEM I Reduced Serum Medium) for 1 h on ice in a 4°C cold room, 1070 
and then rinsed five times with ice-cold Opti-MEM I Reduced Serum Medium to remove 1071 
unbound virions. Cells were either collected immediately (t = 0 h) or further cultured in fresh 1072 
warm Opti-MEM I Reduced Serum Medium supplemented with 5% HI FBS for 2 h at 37°C to 1073 
allow viral entry, and then collected by digestion with 0.25% trypsin-EDTA for 5 min at 37°C. 1074 
RNA extraction and cDNA was performed as described above in the “Quantitative real-time 1075 
PCR analysis” section. For HSV-1 infection, relative mRNA levels of viral immediate early gene 1076 
ICP27 were normalized to that of β-actin (internal control). For SIN infection, cDNA synthesis 1077 
was performed using Invitrogen SuperScript III First-Strand Synthesis System for RT-PCR Kit 1078 
(Thermo Fisher Scientific). Two sets of cDNA were made using either Oligo-dT primer or SIN 1079 
minus-strand RNA-specific primer (SINmsrp), and then used to assess mRNA levels of β-actin 1080 
(internal control) and SIN minus-strand RNA, respectively. The relative quantity of SIN minus-1081 
strand RNA was normalized to that of β-actin mRNA. Primers used in this assay were as 1082 
follows: HSV-1 ICP27 forward primer, 5’-GCGTCGGTCACGGCATAAGG-3’; HSV-1 ICP27 1083 
backward primer, 5’-CGATGACTTACTGGCGGGTG-3’; SINmsrp, 5’-1084 
CTAAAGACTTGAAAGTCATAGCTG-3’; SIN forward primer, 5’-1085 
CACCCCGCACAAAAATGAC-3’; SIN backward primer, 5’-1086 
AAAAGGGCAAACAGCCAACTC-3’. 1087 
Methods for monitoring autophagy induction  1088 
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To monitor autophagy in HeLa cells, we assessed LC3-I to LC3-II conversion and p62/SQSTM1 1089 
levels by western blot analyses and performed GFP-LC3, PI3P and WIPI2 fluorescence 1090 
microscopy. For viral infection experiments, HeLa cells were mock-infected with Opti-MEM I 1091 
Reduced Serum Medium containing 5% HI FBS (normal medium) or infected at 37 for 1.5 h 1092 
with normal media containing certain viruses at an MOI of 20 (for CVB3 and poliovirus), 10 (for 1093 
CHIKV, IAV, SIN, WNV and Zika virus), and 5 (for HSV-1ΔBBD), respectively. After removal 1094 
of virus-containing media, cells were cultured in fresh normal medium for an additional 3 h for 1095 
fluorescence microscopic analyses or 4.5 h for western blot detection of LC3-I/II, p62/SQSTM1, 1096 
ATG7, ATG13 and actin. For mTOR inhibition and nutrient-deprivation experiments, HeLa cells 1097 
were cultured in normal media containing either 250 nM torin 1 or an equivalent volume of 1098 
DMSO, or Earle's Balanced Salt Solution (EBSS, Thermo Fisher Scientific) for 1 h at 37. To 1099 
monitor autophagic flux, bafilomycin A1 (final concentration 100 nM), a lysosomal inhibitor, 1100 
was added to culture media at 1 h prior to fixation (in fluorescence microscopy experiments) or 2 1101 
h prior to cell collection (in western blot experiments). 1102 
Fluorescence microscopy and image analyses 1103 
HeLa cells on Nunc Lab-Tek II 4-well glass chamber slides (Thermo Fisher Scientific) were 1104 
quickly rinsed once with cold DPBS containing Ca2+ and Mg2+ (DPBS-CaMg; Sigma-Aldrich) 1105 
and then fixed with 3% PFA in DPBS-CaMg for 10 min at room temperature. After removal of 1106 
the fixative, cells were rinsed once with DPBS-CaMg. For GFP-LC3 fluorescence microscopy 1107 
using HeLa/GFP-LC3 cells, slides were directly mounted with VECTASHIELD Antifade 1108 
Mounting Medium with DAPI (Vector Laboratories H-1200) and stored at 4 until imaging. For 1109 
immunofluorescence microscopy using HeLa cells, cells were permeabilized in 0.2% saponin in 1110 
DPBS (Sigma-Aldrich D8537) for 15 min at room temperature and then incubated with blocking 1111 
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buffer (DPBS containing 1% BSA and 0.1% saponin) for an additional 30 min. HeLa cells were 1112 
stained with primary antibodies for 1 h at room temperature and rinsed three times with DPBS. 1113 
HeLa cells were then incubated with Alexa Fluor secondary antibodies for 1 h at room 1114 
temperature, rinsed five times with DPBS, mounted with VECTASHIELD Antifade Mounting 1115 
Medium with DAPI (Vector Laboratories H-1200) or ProLong Diamond Antifade Mountant with 1116 
DAPI (Thermo Fisher Scientific P36961) and stored at 4 until imaging. For PI3P fluorescence 1117 
microscopy, HeLa cells were fixed with 4% PFA in DPBS-CaMg for 20 min at room 1118 
temperature followed by a single quick wash with DMEM. Cells were permeabilized with DPBS 1119 
containing 0.1% N-lauroylsarcosine sodium (Sigma-Aldrich L9150) and 2% BSA for 5 min, and 1120 
then incubated with a PI3P-specific fluorescent probe PX-Alexa55528,52 for 15 min. After 1121 
washing with DPBS containing 2% BSA twice, slides were mounted with ProLong Diamond 1122 
Antifade Mountant with DAPI and stored at 4 until imaging. To minimize fluorescent signal 1123 
decay, slides were imaged on the second day after mounting. 1124 
Fluorescent micrographs were acquired using a Zeiss Axio Imager Z2 microscope equipped 1125 
with a Photometrics CoolSnap HQ2 CCD camera using a Zeiss PLAN APOCHROMAT 20X/0.8 1126 
NA wide-field objective or PLAN APOCHROMAT 40X/0.9 NA oil immersion objective. Z-1127 
stack images were acquired with the same acquisition times (for each primary antibody) for 1128 
samples prepared in each batch of experiment. Z-stack images were deconvolved with 1129 
AutoQuant version X2 (Media Cybernetics) and further analyzed with Imaris version 9.3.0 1130 
(Bitplane Inc.) using the same settings for each batch of samples. Background thresholding using 1131 
secondary antibody control staining was applied for all experiments. Random images were 1132 
chosen from greater than 100 cells per well of triplicate samples for each condition for analysis 1133 
by an observer blinded to experimental condition.  1134 
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Acid bypass assay 1135 
To determine whether viral entry at the plasma membrane triggers autophagy, HeLa/GFP-LC3 1136 
cells in Nunc Lab-Tek II 4-well glass chamber slides were rinsed once with ice-cold Opti-MEM 1137 
I Reduced Serum Medium (Opti-MEM) and incubated in ice-cold Opti-MEM on ice for 10 min 1138 
in a 4°C cold room. Cells were then incubated in virus-free ice-cold Opti-MEM (mock infection) 1139 
or ice-cold Opti-MEM containing SIN (strain SVIA, MOI = 50) or HSV-1ΔBBD (MOI = 25) on 1140 
ice in a 4°C cold room for 1 h to allow viral attachment to cell surface. After discarding viral 1141 
inocula, cells were rinsed three times with ice-cold Opti-MEM to remove unbound virions. Cells 1142 
were then incubated with ice-cold Opti-MEM (pH 7.4) or acidic Opti-MEM (pH 5.4) for 10 min 1143 
at 4°C. The pulse of acidic treatment leads to fusion between the viral envelope and cellular 1144 
plasma membrane, and thus viral entry occurs at the plasma membrane instead of conventional 1145 
endolysosomal routes (which is therefore called an “acid bypass”). The medium was replaced 1146 
with warm fresh Opti-MEM supplemented with 5% HI FBS (normal medium) and cells were 1147 
cultured for 2 h at 37°C (to allow viral entry in the control group without acid bypass treatment). 1148 
The medium was replaced with warm fresh normal medium and cells were further cultured for 1149 
an additional 2.5 h at 37°C. GFP-LC3 fluorescence microscopy was performed as described in 1150 
the section “Fluorescence microscopy and image analyses”. To compare viral entry efficiency in 1151 
HeLa cells receiving the two types of pulse treatments (pH 5.4 versus pH 7.4), viral infection 1152 
was performed similarly as described above except that cells were collected at the end of 2-hour 1153 
culture at 37°C (without medium change and without an additional 2.5-hour culture). Viral entry 1154 
efficiency was then examined similarly as described in the section “Assessment of viral entry”. 1155 
Assessment of bacterial xenophagy 1156 
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To study autophagic capture of Group A Streptococcus (xenophagy), Group A Streptococcus 1157 
was grown to mid-log phase and collected by centrifugation at 3,000 g for 5 min. Bacterial 1158 
pellets were rinsed three times with Opti-MEM I Reduced Serum Medium (Opti-MEM). The 1159 
OD600 of bacteria resuspended in Opti-MEM was determined using a GENESYS 30 Visible 1160 
Spectrophotometer (Thermo Fisher Scientific) and the number of viable bacteria (colony-1161 
forming unit [cfu]) was determined on Blood Agar (TSA with 5% Sheep Blood) Plates (Thermo 1162 
Fisher Scientific). To infect wild-type and SNX5KO HeLa/GFP-LC3 cells, cells were incubated 1163 
with antibiotic-free Opti-MEM supplemented with 5% FBS containing Group A Streptococcus 1164 
(at an MOI of 50) for 1 h at 37°C. Cells were washed two times with Opti-MEM to remove 1165 
unbound bacteria, and then cultured in fresh Opti-MEM supplemented with 5% FBS and 1166 
antibiotics (100 μg/ml gentamicin and 100 U/ml penicillin G, which kill the extracellular 1167 
bacteria) for an additional three hours at 37°C. Cells were then fixed for fluorescence 1168 
microscopy analysis as described in the section “Fluorescence microscopy and image analyses”.  1169 
Endolysosomal LC3 lipidation induced by osmotic imbalance 1170 
Wild-type and SNX5KO HeLa/GFP-LC3 cells were cultured in Opti-MEM I Reduced Serum 1171 
Medium supplemented with 5% FBS (normal medium) in Nunc Lab-Tek II 4-well glass chamber 1172 
slides overnight. Hypotonic medium was made by mixing fresh normal medium with sterile 1173 
water (Sigma-Aldrich W4502) at a ratio of 20:80 (vol/vol). Cells were rinsed three times with 1174 
DPBS (Sigma-Aldrich D8537) and then cultured in fresh normal medium or hypotonic medium 1175 
for 1 h. Cells were fixed and immunofluorescence microscopy was performed using the protocol 1176 
described in the section “Fluorescence microscopy and image analyses” and stained for the early 1177 
endosomal marker EEA1 and the lysosomal marker LAMP1. 1178 
Monensin-driven LC3-associated phagocytosis of latex beads 1179 
 
 53
Wild-type and SNX5KO HeLa/GFP-LC3 cells (80,000 cells/well) were cultured in Opti-MEM I 1180 
Reduced Serum Medium supplemented with 5% FBS (normal medium) in Nunc Lab-Tek II CC2 1181 
4-well glass chamber slides (Thermo Fisher Scientific) overnight. Polybead Microspheres (3.00 1182 
μm in diameter) (Polysciences Inc. 17134-15) were washed twice by resuspending the beads in 1183 
sterile PBS and pelleting for 5 min at 2,500 g. Cells were incubated with fresh normal medium 1184 
containing beads (approximately 50 beads per cells) for 4 h. Cells were rinsed three times with 1185 
sterile PBS to remove unengulfed beads and cultured for 45 min in fresh normal medium 1186 
containing 100 μM monensin or an equivalent volume of solvent control (ethanol). Cells were 1187 
rinsed twice with cold PBS and then fixed in ice-cold methanol for 4 min in -20°C. Cells were 1188 
rinsed twice with PBS and blocked in PBS containing 2% BSA (blocking buffer) for 30 min at 1189 
room temperature. Cells were incubated with blocking buffer containing goat anti-LAMP1 1190 
polyclonal antibody for 1 h at room temperature. Cells were rinsed three times in PBS, and then 1191 
incubated with blocking buffer containing Alexa Fluor 594 secondary antibody for 1 h at room 1192 
temperature. Cells were rinsed five times with PBS and slides were mounted with ProLong 1193 
Diamond Antifade Mountant with DAPI and stored at 4 until imaging. Intracellular structures 1194 
containing latex beads were studied with immunofluorescence microscopy and differential 1195 
interference contrast (DIC) microscopy (also known as Nomarski interference contrast 1196 
microscopy).  1197 
Glucose transporter 1 (GLUT1) lysosomal sorting assay 1198 
Retromer activity was monitored by a GLUT1 lysosomal sorting assay as previously described53, 1199 
in which lysosomal localization of mis-sorted GLUT1 serves as an indicator of defective 1200 
retromer activity. HeLa cells were transfected with NC control siRNAs or siRNAs targeting 1201 
SNX5, SNX32, VPS29 and ATG7 for 72 h. Immunofluorescence microscopy was performed 1202 
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using the protocol described in the section “Fluorescence microscopy and image analyses” with 1203 
staining for GLUT1 and LAMP1. Quantitative analyses of colocalization between GLUT1 and 1204 
LAMP1 (Manders’ overlap coefficient) were performed using the ImarisColoc module of Imaris 1205 
version 9.3.0 (Bitplane Inc.). 1206 
Transferrin receptor recycling assay 1207 
To assess the fast and slow recycling activity of plasma membrane-anchored receptors through 1208 
endocytic pathways in HeLa cells, a pulse-chase transferrin receptor recycling assay was 1209 
performed as follows. Wild-type and SNX5KO HeLa cells (12,000 cells/well) were seeded in 96-1210 
well stripwell plates (Corning) at 80% confluency one day prior to the experiment. Cells were 1211 
first rinsed three times with 200 μL assay buffer PBS4+ (PBS supplemented with 1 mM CaCl2, 1 1212 
mM MgCl2, 0.2% BSA and 5 mM D-glucose) and then cultured in 100 μL PBS4+ for 30 min at 1213 
37°C to minimize the background biotin signal. Cells were chilled down in 100 µL ice-cold 1214 
PBS4+ on ice in a 4°C cold room for 5 min, and then incubated with 100 µL PBS4+ (blank 1215 
controls) or PBS4+ containing 5 µg/mL Biotin-transferrin (Biotin-Tfn) (Sigma-Aldrich T3915). 1216 
The blank controls were left on ice until fixation. Biotin-Tfn-treated cells were cultured at 37°C 1217 
for either 10 min or 30 min to allow uptake of Biotin-Tfn into cells, which corresponds to the 1218 
assessment of fast recycling pathway or slow recycling pathway, respectively. Biotin-Tfn uptake 1219 
was stopped by replacing the buffer with 200 μL fresh ice-cold PBS4+ and cells were rapidly 1220 
cooled on ice. Cells were rinsed once with ice-cold PBS4+ to remove excess of unbound Biotin-1221 
Tfn in wells. Cells were then treated with avidin and biocytin to mask surface bound Biotin-Tfn 1222 
as follows. First, cells were incubated in 50 μL ice-cold PBS4+ containing 50 μg/mL Invitrogen 1223 
avidin (Thermo Fisher Scientific 434401) on ice for 10 min. Cells were rinsed twice with ice-1224 
cold PBS4+, and then incubated in 50 μL ice-cold PBS4+ containing 5 μg/mL Invitrogen biocytin 1225 
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(Thermo Fisher Scientific B1592) on ice for 15 min to mask cell surface-bound Biotin-Tfn. Cells 1226 
were rinsed twice with ice-cold PBS4+, and one strip of cells was temporarily stored on ice until 1227 
fixation, which served as the “initial total intracellular Biotin-Tfn content” controls (i.e. t = 0 1228 
min) for the following chase steps. The remaining strips of cells were cultured in 100 μL PBS4+ 1229 
containing 2 mg/mL (saturation concentration) holo-transferrin (Sigma-Aldrich T4132) at 37°C 1230 
for serial chase times (2.5, 5, 10, 20 and 30 min) to allow recycling of endosomal biotin-Tfn-1231 
bound Tfn receptor to the cell surface. To stop the recycling, the buffer was replaced with 100 1232 
μL fresh ice-cold PBS4+. Cells were further rapidly rinsed three times with 200 μL ice-cold wash 1233 
buffer (200 mM acetic acid, 200 mM NaCl, pH 2.3) for 15 sec each wash to remove plasma 1234 
membrane-associated Biotin-Tfn. All strips of cells were rinsed three times with 200 μL ice-cold 1235 
PBS, and fixed in 100 μL 4% PFA in PBS for 30 min at 37°C. Cells were rinsed three times with 1236 
200 μL ice-cold PBS, and permeabilized in PBS containing 0.1% Triton X-100 for 5 min at 1237 
room temperature. Cells were blocked with casein blocking buffer (Sigma-Aldrich B6429) for an 1238 
additional 30 min at room temperature. Cells were incubated with 200 μL Q-PBS buffer (pH 7.4) 1239 
containing 2% BSA, 0.1% lysine, 0.01% saponin and streptavidin-HRP (Roche; 1:10,000) for 1 1240 
h. Cells were rinsed six times with 200 μL PBS for 5 min each wash, and incubated with 200 μL 1241 
o-phenylenediamine dihydrochloride (OPD) solution (Sigma-Aldrich) for 20 min. Reactions 1242 
were stopped by adding 50 μL 5M H2SO4 solution. Absorbance at 490 nm and 650 nm was 1243 
determined using a Synergy H1 Hybrid Multi-Mode Reader (BioTek Instruments). To determine 1244 
the total protein levels in each well, cells were rinsed five times with 200 μL PBS, and then 1245 
incubated with 100 μL Pierce BCA Solution (Thermo Fisher Scientific) on a shaker for 30 min at 1246 
60°C. Absorbance at 562 nm was determined using a Synergy H1 Hybrid Multi-Mode Reader 1247 
(BioTek Instruments). HRP activity was normalized to protein concentration for each well. The 1248 
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percentage of remaining intracellular Biotin-Tfn content for each chase time point was calculated 1249 
in reference to the initial total intracellular Biotin-Tfn content. 1250 
Epidermal growth factor receptor (EGFR) endolysosomal degradation assay 1251 
Endolysosomal function of HeLa cells was assessed by an epidermal growth factor (EGF)-1252 
induced EGFR endolysosomal degradation assay. HeLa cells (180,000 cells/well in 6-well 1253 
plates) were cultured overnight in DMEM supplemented with 10% FBS, 100 units/mL penicillin 1254 
and 100 μg/mL streptomycin. Cells were then starved for 16 h in serum-free DMEM and treated 1255 
with DMEM containing 30 μg/mL cycloheximide for 30 min to suppress protein synthesis. Cells 1256 
were stimulated with 100 ng/mL EGF (Thermo Fisher Scientific PHG0313), and collected at 0, 1257 
0.5, 1, 2 and 4 h, respectively. EGFR and actin protein levels were analyzed by western blot 1258 
analysis. Western blot images were collected using a G:Box Chemi Gel Doc System (Syngene) 1259 
and densitometry analysis of protein bands was performed using the software GeneTools version 1260 
4.3.10.0 (Syngene). Relative EGFR protein levels were normalized to corresponding actin 1261 
controls and then converted to percentage values in reference to unstimulated cells (t = 0 h).  1262 
Viral infectivity assays and viral growth curves 1263 
Viral infection in cultured cells was examined by viral infectivity assays, multi-step growth 1264 
curves and single-step growth curves. For the viral infectivity assay, HeLa cells were seeded in 1265 
12-well plates (100,000 cells per well) in Opti-MEM I Reduced Serum Medium supplemented 1266 
with 5% HI FBS (normal medium) one day prior to infection. Confluent cell monolayers were 1267 
incubated with 2-fold serially diluted viral inoculum in normal medium for 1.5 h. After removal 1268 
of viral inocula, cells were cultured in 1× MEM supplemented with 1% HI FBS and 1% 1269 
methylcellulose (Sigma-Aldrich M0512) for 3 days. Cell monolayers were fixed in methanol for 1270 
15 min at room temperature and then stained in 1× crystal violet solution (containing 0.5% 1271 
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crystal violet and 25% methanol). The numbers of plaques on cell monolayers correspond to the 1272 
numbers of cells that established infection during primary infection with viral inoculum, as 1273 
methylcellulose blocks viral spread through culture medium without affecting viral direct cell-to-1274 
cell transmission. Thus, plaque numbers normalized to viral input for each well indicate the 1275 
relative magnitude of cellular susceptibility to viral infection (i.e. viral infectivity) for each cell 1276 
line.  1277 
To assess viral multi-step growth and single-step growth in HeLa cells, cell monolayers were 1278 
infected with viral inoculum in Opti-MEM I Reduced Serum Medium supplemented with 5% HI 1279 
FBS (normal medium) at MOI of 0.01 and 10 for 1.5 h, respectively. After removal of viral 1280 
inocula, cells were cultured in fresh normal medium for up to 6 days. Viral multi-step growth in 1281 
primary MEFs were assessed similarly as described above, except that MEFs were cultured using 1282 
DMEM supplemented with 10% HI FBS. Viral titers at selected time points were determined by 1283 
plaque assay.  1284 
Co-immunoprecipitation (co-IP)  1285 
To investigate the interaction between endogenous proteins, HeLa cells were treated with PIK-III 1286 
(5 μM) or DMSO for 1 h. HeLa cells were lysed in ice-cold 1× lysis buffer (pH 7.5) containing 1287 
50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, cOmplete 1288 
proteinase inhibitor cocktail (Roche) and Halt phosphatase inhibitor cocktail (Thermo Fisher 1289 
Scientific) on ice for 30 min, and further homogenized by passage through 18-gauge needles 1290 
fitted onto sterile plastic syringes fifteen times. The insoluble fraction of cell lysates was 1291 
removed by centrifugation at 10,000 g and 4 for 15 min. Cell lysates were further cleared by 1292 
incubation with 10 μL Protein G PLUS-agarose beads (Santa Cruz Biotechnology) for 30 min at 1293 
4°C followed by centrifugation at 1,000 g and 4 for 1 min. The total protein concentration of 1294 
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supernatants was determined using a Quick Start Bradford Protein Assay Kit (Bio-Rad 1295 
Laboratories ), and adjusted to the same concentration by adding 1× lysis buffer. Cell lysates 1296 
(equivalent volume for each experimental group) were incubated with anti-beclin 1 and anti-1297 
SNX5 antibodies or an appropriate control IgG for 3 h at room temperature, and then subjected 1298 
to immunoprecipitation by the addition of 25 μL Protein G PLUS-Agarose beads (Santa Cruz 1299 
Biotechnology) for 1 h at room temperature. Agarose beads were pelleted by centrifugation at 1300 
1,000 g and 4 for 1 min and washed five times with ice-cold 1× lysis buffer. 1301 
Immunoprecipitates were eluted by boiling agarose beads in 2× Laemmli sample buffer (Bio-Rad 1302 
Laboratories) containing 5% β-mercaptoethanol (Bio-Rad Laboratories) for 5 min and then 1303 
analyzed by western blot.  1304 
Western blot analyses 1305 
HeLa cell lysates were prepared by incubating cells with ice-cold 1× lysis buffer (pH 7.5) 1306 
containing 50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 1307 
cOmplete proteinase inhibitor cocktail (Roche) and Halt phosphatase inhibitor cocktail (Thermo 1308 
Fisher Scientific) on ice for 30 min. Cell lysates were then centrifuged at 10,000 g and 4 for 15 1309 
min to remove the insoluble fraction. The supernatant was then mixed with an equal volume of 1310 
2× Laemmli sample buffer (Bio-Rad Laboratories) containing 5% β-mercaptoethanol (Bio-Rad 1311 
Laboratories) and boiled for 5 min. Denatured proteins were separated by SDS-PAGE using 4-1312 
20% Mini-PROTEAN TGX precast protein gels (Bio-Rad Laboratories) and transferred to 1313 
Immun-Blot PVDF membranes (Bio-Rad Laboratories). Membranes were blocked with blotting-1314 
grade blocker (Bio-Rad Laboratories) or 2% BSA in 1× PBS buffer containing 0.05% Tween 20 1315 
(PBST), incubated with primary and secondary antibodies diluted according to manufacturers’ 1316 
instructions, and washed five times with 1× PBST. Protein bands were visualized with 1317 
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SuperSignal West Pico PLUS Chemiluminescent Substrate (Thermo Fisher Scientific) on a 1318 
BioSpectrum imaging system (Ultra-Violet Products) or Light Labs Ultra Blue X-ray film (Light 1319 
Labs). Densitometry analysis of protein bands was performed using the software Multi Gauge 1320 
3.0 (FUJIFILM). Relative protein levels were normalized to according actin controls. To further 1321 
validate that viral infection induces degradation of p62/SQSTM1 instead of its translocation into 1322 
the Trion X-100-insoluble fraction, HeLa cells were also lysed in RIPA buffer (Cell Signaling 1323 
Technology) containing 1% SDS after mock or viral infection. Western blot and densitometry 1324 
analyses were performed similarly as described above. 1325 
Expression and purification of Class III phosphatidylinositol 3-kinase (PI3KC3) complexes 1326 
PI3KC3 complexes were prepared using a mammalian expression system from a suspension 1327 
culture of HEK293F cells. Expression plasmids for PI3KC3 complex components include 1328 
pCAG-OSF-ATG14 for Strep-Flag tagged human ATG14, pCAG-OSF-UVRAG for Strep-Flag 1329 
tagged human UVRAG, pCAG-NT-P150 for human VPS15 (also known as p150), pCAG-NT-1330 
VPS34 for VPS34 (also known as PI3KC3 or PIK3C3), and pCAG-NT-beclin1 for beclin 154. To 1331 
obtain PI3KC3-C1 complexes (containing ATG14, VPS15, VPS34 and beclin 1) and PI3KC3-1332 
C2 complexes (containing UVRAG, VPS15, VPS34 and beclin 1), two plasmid cocktails (0.5 1333 
mg per plasmid per 1 L culture medium), were respectively transfected into HEK293F cells 1334 
(when cell density reached 1,000,000 cells/mL) using polyethylenimine (PEI) at the mass ratio 1335 
1.5:1 (PEI:plasmids). HEK293F cells were cultured in a 37 incubator with a humidified 1336 
atmosphere with 8% CO2 in air on an orbital shaker rotating at 120 rpm for three days. 1337 
For purification of PI3KC3 complexes, HEK293F cells were collected at 72 h after 1338 
transfection by centrifugation at 400 g and 4 for 20 min. Cell pellets were then lysed in ice-1339 
cold 1× lysis buffer containing 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM dithiothreitol 1340 
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(DTT), 1% Triton X-100 and protease inhibitor cocktail (Roche) on ice for 10 min. After 1341 
centrifugation at 13,000 g and 4 for 30 min, the supernatant was filtrated through a 0.45-μm 1342 
filter (Roche). Precleared supernatant was incubated with StrepTactin Sepharose High 1343 
Performance resin (GE Healthcare) for 1 h at 4. The resin was carefully washed three times 1344 
with ice-cold washing buffer containing 100 mM Tris-HCl (pH 8.0), 300 mM NaCl and 1 mM 1345 
DTT. PI3KC3 complexes were eluted with 10 mM desthiobiotin (Sigma-Aldrich) and 1346 
concentrated by centrifugation using Amicon Ultra-15 Centrifugal Filter Units 100K (EMD 1347 
Millipore) at 4. Concentrated eluate was further purified by gel filtration using Superose 6 1348 
Increase 3.2/300 pre-packed high performance glass columns (GE Healthcare) at 4, which were 1349 
equilibrated with the gel filtration buffer containing 20 mM Tris-HCl (pH 8.0), 150 mM NaCl 1350 
and 1 mM DTT. PI3KC3 complex peak fractions were combined and stored in small aliquots at -1351 
80 after being snap-frozen in liquid nitrogen. The concentration of PI3KC3 complex eluates 1352 
was quantitated using the protein A280 method. The purity of protein complexes was examined 1353 
by SDS-PAGE and Coomassie blue staining using GelCode Blue Safe Protein Stain (Thermo 1354 
Fisher Scientific 24594) according to the manufacturer’s instruction. 1355 
Amino Acid Sequence Alignment and Secondary Structure Prediction of SNX5 and Closely-1356 
related Sorting Nexins 1357 
Amino acid sequence of nine vertebrate SNX5 homologs and four closely-related human sorting 1358 
nexins (SNX1, SNX2, SNX6 and SNX32) were acquired form National Center for 1359 
Biotechnology Information (NCBI) Reference Sequences (RefSeq) database. Their NCBI 1360 
accession IDs are as follows: zebrafish snx5, NP_999934; frog snx5, NP_001016081; snake 1361 
SNX5, XP_025024423; Lizard snx5, XP_003219930; chick SNX5, NP_001006178; mouse 1362 
Snx5, NP_001186117; pig SNX5, XP_020933988; chimpanzee SNX5, XP_016792968; human 1363 
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SNX5, NP_689413; human SNX1, NP_003090; human SNX2, NP_003091; human SNX6, 1364 
NP_689419; human SNX32, NP_689973. Amino acid sequence alignment of proteins was 1365 
performed using Cluster Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/). Protein secondary 1366 
structure prediction was performed using the University College London (UCL) PSIPRED 1367 
Protein Sequence Analysis Workbench (http://bioinf.cs.ucl.ac.uk/psipred/). 1368 
Expression and purification of recombinant SNX5 proteins 1369 
Wild-type SNX5 and a mutant SNX5 EEE (that carries triple mutations K328E/R330E/K332E) 1370 
were prepared using a bacterial expression system. The coding region of SNX5 and SNX5 EEE 1371 
were cloned into BamHI/SalI sites of the ppSUMO vector, a modified pET-28a vector that 1372 
contains an N-terminal hexa-histidine-tag followed by a SUMO-tag and a recognition site for 1373 
SUMO protease, Ulp. The empty vector and SNX5 plasmids were transformed into the 1374 
chemically competent E. coli strain BL21(DE3) and grown to an optical density at a wavelength 1375 
of 600 nm (OD600) of 0.8 in 2× YT medium. Protein expression was induced by addition of 1376 
0.2 mM isopropyl-β-D-thiogalactopyranoside (IPTG) followed by overnight culture at 16. 1377 
Cells were lysed in 1× bacterial lysis buffer containing 20 mM Tris (pH 8.0), 500 mM NaCl, and 1378 
2 mM β-mercaptoethanol by French pressing using Emulsiflex-C5 (AVESTIN). Cell lysates 1379 
were cleared by centrifugation at 15,000 g and 4 for 1 h. Proteins in the lysates were purified 1380 
using 1 mL HisTrap columns (GE Healthcare) and size exclusion chromatography using 1381 
Superdex 200 increase 10/300 gel filtration columns (GE Healthcare) equilibrated with a buffer 1382 
containing 20 mM Tris (pH 8.0), 150 mM NaCl, and 2 mM DTT. SUMO control, SUMO-SNX5 1383 
and SUMO-SNX5 EEE were further concentrated by centrifugation using Amicon Ultra-15 1384 
Centrifugal Filter Units 10K (EMD Millipore) and stored in small aliquots at -80 after being 1385 
snap-frozen in liquid nitrogen. Protein concentration and quality was assessed as described 1386 
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above. Approximately 0.1 nanomole of SUMO control, SUMO-SNX5 and SUMO-SNX5 EEE 1387 
was loaded per lane on an SDS-PAGE gel. 1388 
In vitro binding assay 1389 
To determine whether SNX5 directly binds PI3KC3-C1 or PI3KC3-C2 complexes, 0.2 nanomole 1390 
of bacterially-purified SUMO control, SUMO-SNX5 and SUMO-SNX5 EEE were incubated 1391 
with PI3KC3-C1 or PI3KC3-C2 complexes on Strep-Tactin resin or empty resin in 1× binding 1392 
buffer containing 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM DTT, 1% Triton X-100 and 1393 
protease inhibitor cocktail (Roche) for 3 h at room temperature. Strep-Tactin resin was pelleted 1394 
by centrifugation at 1,000 g for 1 min and washed six times with ice-cold 1× binding buffer. 1395 
Captured protein complexes were eluted by boiling resin in 2× Laemmli sample buffer (Bio-Rad 1396 
Laboratories) containing 5% β-mercaptoethanol (Bio-Rad Laboratories) for 5 min and then 1397 
analyzed by western blot. 1398 
Liposome preparation 1399 
The lipid substrate for the in vitro lipid kinase assay was phosphatidylinositol (PI) incorporated 1400 
on Large Unilamellar Vesicles prepared by Extrusion Technique (LUVETs)29,30 using a lipid 1401 
mixture that resembles endosomal lipid composition31,32. PI-containing liposomes were 1402 
composed of 47.5% porcine brain phosphatidylcholine (PC, Avanti Polar Lipids 840053), 23% 1403 
porcine brain phosphatidylethanolamine (PE, Avanti Polar Lipids 840022), 10% bovine liver PI 1404 
(Avanti Polar Lipids 840042), 9% porcine brain sphingomyelin (SM, Avanti Polar Lipids 1405 
860062), 8.5% porcine brain phosphatidylserine (PS, Avanti Polar Lipids 840032), and 2% 1406 
protonated phosphatidylinositol 4,5-bisphosphate (PI[4,5]P2, Avanti Polar Lipids 840046). PI-1407 
free control liposomes were composed of similar lipid composition except that PI was replaced 1408 
with PS. Six mM of lipid components were mixed together in 1:1 (vol/vol) chloroform:methanol 1409 
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and dried in glass tubes under a stream of nitrogen. The lipid film was further vacuum-dried for 2 1410 
h at room temperature and then rehydrated into 1× liposome buffer containing 20 mM Tris-HCl 1411 
(pH7.5), 150 mM NaCl and 1 mM DTT. Lipids were subjected to ten cycles of freeze and thaw 1412 
between liquid nitrogen and a 42 water bath, and then extruded twenty-one times through 1413 
polycarbonate filters with pore sizes of 100 nm or 30 nm in diameter (Avanti Polar Lipids). 1414 
These LUVETs of two sizes are respectively designated as “larger” and “smaller” liposomes in 1415 
this study. Liposomes were stored in glass vials at 4 and used for in vitro lipid kinase assay 1416 
within 24 h. 1417 
In vitro lipid kinase assays 1418 
The kinase reactions were performed in 8-tube strip PCR tubes at a ratio of 1:1:1 (vol/vol/vol) 1419 
for PI-containing or PI-free liposomes (2 mM of total lipids) (1/3 volume), purified PI3KC3-C1 1420 
and varying concentrations of SNX5 diluted in 1× liposome buffer (1/3 volume) and a kinase 1421 
reaction buffer containing ATP (1/3 volume; added at the last step to initiate the reaction). The 1422 
kinase reaction buffer consisted of 20 mM Tris-HCl (pH7.5), 105 mM NaCl, 30 mM MgCl2, 1 1423 
mM DTT and 300 μM ATP, which has the same osmotic pressure as the 1× liposome buffer. The 1424 
reactions were carried out for 30 min at 37. ATP consumption in each reaction was assessed 1425 
using an ADP-Glo Kinase Assay Kit (Promega).  1426 
Cryogenic electron microscopy (cryo-EM) and assessment of liposomal curvature 1427 
To investigate SNX5-induced liposomal deformation, the “larger” LUVETs (extrusion filter pore 1428 
size: 100 nm in diameter) containing 2 mM total lipids were incubated with 800 nM of SUMO 1429 
control, SUMO-SNX5 and SUMO-SNX5 EEE in 1× liposome buffer (without PI3KC3-C1 and 1430 
ATP) for 30 min at 37°C. Lacey Carbon film 300 mesh Copper grids (Agar Scientific AGS166-1431 
3) were glow-discharged at 30 mA for 40 seconds in a Pelco easiGlow Glow Discharge Cleaning 1432 
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System (Ted Pella). A drop (3.5 μL) of the suspension was then applied onto the carbon-coated 1433 
side of a specimen grid held by forceps in the blotting position inside the environmental chamber 1434 
(humidity 100%) of FEI Vitrobot (Thermo Fisher Scientific) at room temperature. Grids were 1435 
immediately blotted at a force of 12 for 4 seconds, plunged into the liquid ethane, and then stored 1436 
in liquid nitrogen until imaging. The specimens were examined in liquid nitrogen using an FEI 1437 
Talos Arctica TEM (Thermo Fisher Scientific). Micrograph were collected at a magnification of 1438 
28,000 under 300 kV and low-dose condition (approximately 20 e-/Å2) using an FEI Eagle 4k × 1439 
4k CCD.  1440 
In cryo-EM micrographs, liposomes display in the form of either circular or elliptical shapes 1441 
(in two-dimensional space), which correlate with spherical and ellipsoid shapes of the liposome 1442 
(in three-dimensional space). For each experimental group, the lengths of the major axis (2a) and 1443 
minor axis (2b) of an ellipse were quantitated for at least 150 liposomes per condition. Since the 1444 
circle can be considered as a unique ellipse with two foci at the same spot (the center), 2a is 1445 
equal to 2b for a circle. Unlike a constant curvature along the circle, an ellipse has continuously 1446 
altering curvature with the highest curvature seen at two vertex points. In differential geometry, 1447 
the radius of curvature (R), which is the reciprocal of the curvature (κ), inversely correlates with 1448 
the magnitude of curvature. The radius of curvature at vertex points of an ellipse was quantitated 1449 
and compared between experimental groups. 1450 
Animal studies 1451 
Animal studies were performed in a barrier facility at the University of Texas Southwestern 1452 
Medical Center. Mice were raised under the following housing conditions: ambient temperature, 1453 
70°F to 75°F; humidity, 30% to 50%; normal light-dark cycle (lights on 6 a.m. and lights off 6 1454 
p.m.); chow, Teklad Global 16% Protein Rodent Diet (Envigo 2916); water, reverse osmosis 1455 
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water. For in vivo studies, intracerebral (i.c.) infection was performed for HSV-1, SIN and WNV, 1456 
and subcutaneous infection was performed for CHIKV. All intracerebral infections were 1457 
performed by injecting virus diluted in 30 μL Hank’s Balanced Salt Solution (HBSS, Thermo 1458 
Fisher Scientific) in the right cerebral hemisphere. For HSV-1 infection, eight- to ten-week-old 1459 
littermate Snx5+/+ and Snx5-/- mice were infected i.c. with 50,000 plaque-forming units (pfu) of 1460 
HSV-1ΔBBD or HSV-1ΔBBD-MR. Since HSV-1ΔBBD-MR is significantly more virulent than 1461 
HSV-1ΔBBD, this strain was also administrated using a lower dose (500 pfu, i.c.) to ensure that 1462 
differences observed between Snx5+/+ and Snx5-/- mice in susceptibility to infection with HSV-1463 
1ΔBBD is truly specific for HSV-1 strains that lack the ability to inhibit host autophagy. For SIN 1464 
infection, seven-day-old Snx5+/+ and Snx5-/- neonatal mice were infected i.c. with 1,000 pfu of 1465 
SIN strains dsTE12Q or dsTE12Q.dnAtg5 (SIN.dnAtg5). For WNV infection, 5.5-day-old 1466 
Snx5+/+ and Snx5-/- neonatal mice were infected i.c. with 1 pfu of WNV strain Egypt-101. For 1467 
infection with CHIKV, seven-day-old Snx5+/+ and Snx5-/- neonatal mice were infected 1468 
subcutaneously with 100,000 pfu of CHIKV strain 06-021 in 30 μL HBSS. All mice were 1469 
monitored daily. Infected animals were randomly chosen for tissue collection at designated time 1470 
points post infection. To assess viral loads in mouse brains, 10% (weight/volume) homogenates 1471 
of the right hemispheres were prepared by grinding brains in HBSS followed by either three 1472 
freeze-thaw cycles (for HSV-1) or no freeze-thaw cycle (SIN), and then assessed by plaque assay 1473 
titration. For histopathology studies, the left hemispheres were fixed in 4% PFA, embedded in 1474 
paraffin, and further analyzed by immunohistochemistry assays as described below. For 1475 
mortality studies, mice that survived from viral infection were euthanized on day 21 post 1476 
infection. Since the in vivo virulence of SIN.dnAtg5 is much lower than the parental strain 1477 
dsTE12Q, SIN.dnAtg5-infected mice were monitored until day 28 post infection and all 1478 
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surviving mice were euthanized at the end of the experiment. All animal procedures were 1479 
performed in accordance with institutional guidelines and with approval from the Institutional 1480 
Animal Care and Use Committee of the University of Texas Southwestern Medical Center. 1481 
Histology 1482 
Five-μm-thick sagittal sections of mouse brain were prepared using PFA-fixed and paraffin-1483 
embedded samples. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 1484 
staining of mouse brain sections was performed using Apoptag Peroxidase In Situ Apoptosis 1485 
Detection Kit (EMD Millipore) and SIGMAFAST 3,3’-diaminobenzidine tablets (DAB; Sigma-1486 
Aldrich) according to the manufacturers’ instructions. High-resolution montages of the entire 1487 
sagittally sectioned mouse brain slides were acquired using a Zeiss Axio Scan.Z1 slide scanner 1488 
equipped with a Zeiss PLAN APOCHROMAT 20X/0.8 NA objective (Carl Zeiss Microscopy), 1489 
and then analyzed with NDP.view version 2.3.13 (Hamamatsu Photonics). The number of 1490 
TUNEL-positive foci per mouse brain sections was determined by an observer blinded to 1491 
experimental condition. 1492 
Statistical analyses 1493 
Statistical analyses for genome-wide siRNA screens are described in the section “High-content 1494 
image-based genome-wide siRNA screens”. Where appropriate, two-sided statistical tests were 1495 
used throughout this study. For Kaplan-Meier survival curves in animal studies, log-rank tests 1496 
(two-sided) were performed using the software Prism 8 version 8.3.0 (GraphPad Software). For 1497 
in vivo pathogenesis analysis and all the in vitro assays, P values were determined using the 1498 
open-source R software package version 3.6.2 (www.r-project.org). Unpaired two-tailed t-tests 1499 
were used for comparisons of two means, and one-way ANOVA analysis with Dunnett’s test for 1500 
multiple comparisons was performed to assess the significance of multiple experimental groups 1501 
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versus a control condition. Two-way ANOVA analysis was performed to assess the significance 1502 
of the interaction of two independent variables. Linear regression analysis was used to assess the 1503 
dose-dependent effect of a variable, and two- or three-way interaction terms in these linear 1504 
models were then used to determine the significance of differences of dose-dependent effects 1505 
between different treatment groups.  1506 
 1507 
Data availability 1508 
All relevant data supporting the findings of this study are available within the manuscript and its 1509 
supplementary information files.  All figures, including Figs. 1 - 3 and Extended Data Figs. 1, 3 - 1510 
10 have associated raw data. Original blots are available in Supplementary Fig. 1. Original 1511 
protein sequences were acquired from the NCBI RefSeq database, and the link to this database 1512 
and protein accession numbers are provided in the Amino Acid Sequence Alignment section of 1513 
the Methods. 1514 
 1515 
Code availability 1516 
Custom codes (for R packages) used in siRNA screen analyses are available from the GitHub 1517 
database (https://github.com/xiao-zang/snx5). 1518 
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Supplementary Table 1. 1 
Statistical analysis for primary siRNA screens using a mixed-effects Poisson regression model in 2 
which GFP-LC3 puncta numbers/cell served as response variable, siRNA treatment (using 3 
negative control wells as references) served as the independent variable, and a random intercept 4 
was included to model the correlated observations among cells within each well.  5 
 6 
Supplementary Table 2. 7 
Statistical analysis of primary siRNA screens using a mixed-effects Poisson regression model in 8 
which GFP-LC3 puncta numbers/cell served as response variable, random intercepts were used 9 
to account for correlated intra- and inter-cell observations in the same assay plate, and fixed 10 
effects included siRNA treatment and viral infections with their interactions.  11 
 12 
Supplementary Table 3. 13 
Statistical analysis results for deconvolution siRNA screens. Shown are the scores (coefficient 14 
values) and Wald-test P-values (two-sided) for each Dharmacon siRNA oligonucleotide 15 
corresponding to 310 genes that scored positive in the primary siRNA screens and for each assay 16 
plate. “N/A”, failed regression of statistical models. NC, non-targeting control siRNA.  17 
 18 
Supplementary Table 4. 19 
Data from Extended Data Fig. 2g with additional details including Entrez gene ID, UniProtKB 20 
ID, gene name, subcellular location, function, and gene involvement in all the categories from 21 
several gene ontology databases (such as GO Terms, INTERPRO, UP, SMART, PIR, KEGG, 22 
BIOCARTA, COG, BBID and OMIM).  23 
 24 
Supplementary Table 5. 25 
Data from Extended Data Fig. 2h, i for all the 174 categories (terms) from DAVID 26 
Bioinformatics Resources containing at least 2 confirmed hits and hypergeometric test P-values 27 
< 0.05. Details include source, number of confirmed hits, corresponding UniProtKB ID and gene 28 
symbol, P-value, enrichment score (-log10[P-value]) and FDR adjusted P-value. 29 
 30 
Supplementary Figure 1. 31 






















































































































































































































































































































































































































SIN (41) HSV-1 (21)COMMON (154)
a 
ifzy-




Larger LUVETs Smaller LUVETs 
n::�::t::: 
0.5 0 200400800 
0
.5 0 200400800 
SUMO proteins (nM) 
+ Pl3KC3-C1 + SUMO 
..,_ Pl3KC3-C1 + SUMO-SNX5 




� & � e 0 fii ,JJ- <if �"' ,g,
"' 
o.ll lll /l if(j _f!?-¥# His-SUMO-




150 �: f His-
}go100 SUMO 8 SUMO 
so 
75 - - - -SNXS 8 
37 
50 - � 
37 - [: 
�g �6 - _ SUMO g 
1g 16 
! �=�lin 1LI -----=-=-=-=-=----_,[�
a_ 
d 












I: t-- �@ 
� oL--�-�-=-:::­
Buffer SUMO SUMO SUMO 













h "jj";' :;::: (1) .----, � [s 0.8 � � 0.6 
-� j 0.4 
�� 0.2 
uZ 








"' "" � 
XE 
ti5 g 40 









,.e_,;,0.0001 � 8 
ro Q P<0.0001 
E� 6 
0 "












SNX5 SNX5 EEE 
KO+ vector 
■ WT +vector 
□ KO+ vector 
P=0.061 □ KO+SNX5 
,..e...,o.260 
■ KO+ SNX5 EEE 
P=0.846 
E2-EEA1+ 
Fig. 
3


Δ







